A Study on Bacterial and Fungal Isolates and their 

Antimicrobial susceptibility pattern in patients with 

Chronic Osteomyelitis in a Tertiary Care Hospital. by Devi, C
ASTUDY ON BACTERIAL AND FUNGAL ISOLATES
AND THEIR ANTIMICROBIAL SUSCEPTIBILITY
PATTERN IN PATIENTS WITH CHRONIC
OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL
Dissertation submitted to
THE TAMILNADU DR.M.G.R.MEDICAL UNIVERSITY
in partial fulfillment of the regulations
for the award of the degree of
M.D. (MICROBIOLOGY)
BRANCH – IV
MADRAS MEDICAL COLLEGE,
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY
CHENNAI – TAMILNADU
APRIL 2013
CERTIFICATE
This is to certify that this dissertation titled “A STUDY ON
BACTERIAL AND FUNGAL ISOLATES AND THEIR
ANTIMICROBIAL SUSCEPTIBILITY PATTERN IN PATIENTS WITH
CHRONIC OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL” is a
bonafide record of work done by DR.C.DEVI, during the period of her Post
graduate study from 2010 to 2013 under guidance and supervision in the
Institute of Microbiology, Madras Medical College and Rajiv Gandhi
Government General Hospital, Chennai-600003, in partial fulfillment of the
requirement for M.D. MICROBIOLOGY degree Examination of The
Tamilnadu Dr.M.G.R. Medical University to be held in April 2013.
DR.G.JAYALAKSHMI.,
M.D., DTCD
Director
Institute of Microbiology,
Madras Medical College &
Rajiv Gandhi Government
General Hospital
Chennai -600 003
Dr.V.KANAGASABAI., M.D.
Dean
Madras Medical College &
Rajiv Gandhi Government
General Hospital,
Chennai -600 003
DECLARATION
I declare that the dissertation entitled “A STUDY ON BACTERIAL
AND FUNGAL ISOLATES
PATTERN
AND
IN
THEIR ANTIMICROBIAL
WITH CHRONICSUSCEPTIBILITY PATIENTS
OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL” is submitted by
me for the degree of M.D. is the record work carried out by me during the
period of October 2011 to September 2012 under the guidance of
Prof.Dr.S.THASNEEM BANU, M.D. Professor of Microbiology, Institute of
Microbiology, Madras Medical College, Chennai. This dissertation is
submitted to the Tamilnadu Dr.M.G.R. Medical University, Chennai, in
partial fulfillment of the University regulations for the award of degree of
M.D., Microbiology (Branch IV) examination to be held in April 2013.
Place: Chennai
Date :
Signature of the Candidate
(Dr.C.DEVI)
Signature of the Guide
Prof.Dr.S.THASNEEM BANU, MD.,
Professor,
Institute of Microbiology,
Madras Medical College,
Chennai.
ACKNOWLEDGEMENT
I express my heartfelt thanks to Honourable dean Dr.V.Kanagasabai M.D.,
Madras Medical College & RGGGH, Chennai for permitting me to carry out this study.
I express my deep sense of gratitude and indebtedness to
Dr.G.Jayalakshmi M.D., Director and Professor of Microbiology, Institute of
Microbiology, Madras Medical College and RGGGH, Chennai, for suggesting
the topic for my dissertation and for her valuable advice, constant guidance
and inspiration in the preparation of this work.
I consider it my privilege and honour to have worked under the guidance,
encouragement and supervision of Dr.S.Thasneem Banu M.D., Professor.
I express my immense thanks to all the Professors of the Institute of
Microbiology,Dr.S.Vasanthi M.D., Dr.S.G.Niranjana Devi M.D.,
DR.T.Sheila Doris M.D., and Dr.U.Uma Devi M.D., for their valuable
advice given to me.
I also express my sincere thanks to the former directors, Dr.G.Sumathi M.D,
Dr.R.Manjula M.D and Dr.Md. Meeran M.D.
I sincerely thank Dr.J.Sasikala M.D., Retired Professor of
Microbiology.
I am extremely grateful to Prof.Dr.M.R.Rajasekar M.S. Ortho, D.Ortho.,
HOD, Institute of Orthopaedics, RGGGH, Chennai, for permitting me to carry
out the study in his department.
Iexpress my heartful thanks to my co-guide Dr.C.S.Sripriya M.D., for
guiding me in the dissertation work
I express my deep sense of gratitude and thanks to Dr.Lata Sriram M.Sc, Ph.D,
Dr.R.Deepa M.D., Dr.N.Rathnapriya M.D.Dr.K.Usha Krishnan M.D.,
Dr.K.G.Venkatesh M.D., Dr.N.Lakshmi Priya M.D., Dr.David Agatha M.D.,
Dr.B.Natesan, M.D., Assistant Professors, Institute of Microbiology, Madras
Medical College, Chennai.
I take this opportunity to thank all the post graduate students of
Institute of Microbiology, for their kind support and encouragement.
My thanks to all the technical and non technical staffs of Institute of
Microbiology, for their help at different stages of this study.
I affectionately thank Mrs.C.Manimegalai, my mother and my
husband DR.J.Pazhani for taking great care of my children, their constant
love, support and encouragement without which this work would not have
been possible.
I also affectionately thank my brother Mr.C.Selvamuthukumar B.E
for helping me in doing dissertation work.
My special thanks to Shajee Computers, Chennai, for working hard on
shaping the dissertation book.
Last but not the least I am very grateful to all the patients without
whom this study would not have been completed.
TABLEOF CONTENTS
S.No TITLE PAGE.NO
1. INTRODUCTION 1
2. REVIEW OF LITERATURE 4
3. AIMS AND OBJECTIVE 24
4. MATERIALS AND METHODS 25
5. RESULTS 47
6. DISCUSSION 71
7. SUMMARY 78
8. CONCLUSION 80
9. BIBLIOGRAPHY
10. (i) ETHICAL COMMITTEE CERTIFICATE
(ii) PATIENT PROFORMA
(iii) ABBREVIATIONS
iv)APPENDIX
(v) MASTER CHART
LISTOF TABLES & CHARTS
S.NO
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
TITLE
AGE AND SEX DISTRIBUTION
DURATION OF ILLNESS
CORRELATION OF SEX AND DURATION OF
ILLNESS
CORRELATION OF AGE AND DURATION OF
ILLNESS
PREDISPOSING FACTORS
SITE OF INFECTION
SITE OF INFECTION AGE GROUP
CORRELATION
SAMPLES COLLECTED FROM THE STUDY
GROUP
CULTURE POSITIVITY
CORRELATION BETWEEN TYPE OF SPECIMEN
COLLECTED AND TYPE OF PATHOGEN
ISOLATED
ORGANISMS ISOLATED
COMBINATION OF ISOLATES IN MIXED
INFECTIONS
ANTIMICROBIAL SUSCEPTIBILITY PATTERN
OF GPC
ANTIMICROBIAL SUSCEPTIBILITY PATTERN
OF GNB
DRUG RESISTANCE MECHANISMS AMONG
PATHOGENS
ESBL DETECTION
DRUG SUSCEPTIBILITY PATTERN OF
M.TUBERCULOSIS
MIC OF VANCOMYCIN
MIC OF ANTIFUNGAL AGENTS
PAGE. NO
47
48
49
50
51
52
54
56
57
58
11.
12.
13.
14.
15.
16.
17.
18.
19.
59
61
62
64
66
68
69
69
70
INTRODUCTION
The word Osteomyelitis is a combination of Greek word “Osteon”
meaning bone and “Myelos” meaning marrow plus the suffix “Itis” meaning
inflammation. [1]
Osteomyelitis is acquired in three ways. They are direct seeding of
microorganisms into bone due to trauma or surgery,haematogenous spread of
microorganisms from the focus of infection elsewhere in the body and spread
from surrounding infected softtissues and joints[2] .
In t he infected bo ne, the infect io n may be unifocal or mult ifocal. I n
unifocal invo lvement, only a single regio n of t he bone is affected. I n
mult ifocal involvement, more t han o ne regio n o f bone such as marrow,
perio steum, cortex and t he surrounding so ft tissue are involved.
Commonly t he infect ion is mo no microbial. Infect ion due to mult iple
organisms [3 ] are usually seen in pat ient s with Diabetes mellit us wit h ulcer
in t he foot.
Chronic Osteo myelit is o f lo ng bo nes is o ften t he consequence o f an
open, comminuted fracture and inadequately treated infect ion of t he
fracture site. Rarely it occurs as a co mplicat io n of acute osteomyelit is
now-a-days.
The following six components characterise chronic osteomyelitis.
1) Sequestrum formation or sclerosis.
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2) Radiological changes seen in bone due to infection for 6 weeks or
longer.
3)
4)
5)
6)
Relapse or persistence of infection after initial treatment.
Osteomyelitis due to foreign bodies.
Osteomyelitis in association with peripheral vascular disease.
Organisms
tuberculosis)
The pathological process involves the necrosis of bone, granulation
that produce chronic disease (e.g Mycobacterium
tissue formation, absorption of necrotic cancellous bone ,replacement by new
bone formation and cicatrix formation due to neighbouring softtissue
destruction. Sequestrum is the dead bone that has been separated from the
living bone. Involucrum is the new bone formed.
The commonest presenting symptoms are persistent pain and chronic
intermittent discharge through sinuses. Bone debris and sequestra find exit
through multiple openings in an involucrum, go through the sinus tracts and
present to the surface. In children, after discharge of sequestrum, the sinus is
closed and the cavity is filled with new bone. In adults, the sinus is not closed
and the persistence of viable pathogens in cavities for a longer period leads to
reactivation of infection at any time.
Chronic osteomyelitis still remains a major challenging problem in our
country .In the majority of cases, it is due to delay, neglect or inadequate
2
treatmentof acute hematogenous osteomyelitis and compound fractures. [4]
The usual complications of chronic osteomyelitis are reduced rate of
growth,pathological fracture, septic arthritis, lengthening of bone, contracture
of muscles. Other rare complications are formation of epithelioma, secondary
amyloidosis [5] ,squamous cell carcinoma in scar tissue(<1%).
Chronic osteomyelitis is a disease which is difficult to eradicate
completely. There may be subsidence of systemic symptoms,but the cavities
containing purulent material, infected granulation tissue or sequestrum act as
foci of infection. There may be recurrent acute flare-ups occuring at indefinite
intervals over months and years. To achieve eradication of the
disease,aggressive surgical debridement with curettage of cavities, filling of
cavities with soft tissues and effective antimicrobial treatment is required [6] .
The pattern and behaviour of organisms
[7]
are constantly
changing under the pressure of newer antibiotics .As a result the wonder
drugs of fifties have been relegated to a position of limited usefulness today.
With this background, it is felt worthwhile to study the spectrum of organisms
causing osteomyelitis and their antimicrobial susceptibility pattern.
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REVIEWOF LITERATURE
GENERAL CONCEPTS OF THE DISEASE
Historical features
Years before, the surgeons charaka and sushruta (2500 BC) made the
first documentation of Osteomyelitis in their writings. Subsequently
Hippocrates accurately described it as an infection of the bony sequestrum.
Sequestrum formation was first described by the physician John Hunter. An
Egyptian HEARST PAPYRUS introduced casts, made of starch such as barley
flour that would harden, similar to today’s plaster of paris. Edwin Smit h
Papyrus (Paul D, 1999) was the one who initially recognised the danger of
infection with open fractures. Historically Osteomyelitis was present in war
scenarios,where the most frequent cause of Osteomyelitis was trauma. In the
last few decades Osteomyelitis occurred after surgical interventions for the
treatment of fractures.
Osteomyelitis is a condition in which there is an acute or chronic
inflammatory process occuring in the bone and its structure due to infection
with pyogenic organisms. It is an infection in the bonemarrow that spread to
the bone cortex and periosteum via the haversian canals. [8] As the bone cortex
is thin in the region of metaphysis, microorganisms get easy access to the
periosteum. Exogenous or Haematogenous spread are the most common routes
of infection that occurs in the bone. Exogenous Osteomyelitis is caused by
penetrating wounds, Compound fractures and Simple fractures treated
surgically with Open reduction and other Orthopaedic appliances like plates,
nails, screws and pins which
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introduce microbial infection
directlyinto the bones.The haematogenous form is due to bacteremia.
Various classification systems for Osteomyelitis are available.They are
Waldvogel and Cierny-Mader classification system. Waldvogel[9] classified
the disease as haematogenous,contiguous and chronic .Cierny Mader [10]
classification system is for staging Chronic Osteomyelitis. This staging
system depends on the status of disease process and the conditions of the
patients and their treatments. Staging is done both anatomically and
physiologically. Under anatomical type there are four stages as medullary,
superficial, localized and diffuse. Under physiological type, healthy hosts are
classified as A host, hosts with systemic, local and both local and systemic
compromising factors as Bs, Bl, Bls and hosts in whom treatment made worse
than the disease as C host. Systemic factors include malnutrition, diabetes mellitus,
hepatic or renal failure, immunosuppression. Local factors include venous stasis,
chronic lymphedema, arteritis, small vessel disease, tobacco abuse.
1. ACUTE HAEMATOGENOUS OSTEOMYELITIS
This type of Osteomyelitis is most commonly seen in children [11,12] .
Over the last several decades the incidence of acute Osteomyelitis has
dramatically decreased due to higher standard of living and improved
hygiene.
EPIDEMIOLOGY
Children are most commonly affected. The most common age group
affected are children less than two years old and children eight to twelve
years. Hence Bimodal[13] age distribution is seen. It is more common in males,
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occuringthree to four times more frequent than in females. Blyth etal,
reported a 70% decrease in the incidence of Osteomyelitis over the past few
years. A higher standard of living and improved hygiene probably have
contributed to this trend.
PATHOGENESIS
It involves mostly the metaphyses of long bones. The tibia followed by
femur [14] are the two
infection to the
most common bones affected. . The predilection of
region is explained by its peculiarmetaphyseal
anatomy.Metaphyseal capillaries lack phagocytic cells, the hairpin bend like
anatomy of the nutrient capillaries near the growth plate favours vascular
stasis. A minor trauma triggers the event by producing a small haematoma
which in turn cause vascular obstruction leading to necrosis of the affected
part of the bone. This area will serve as a bed for the organism resulting from
transient bacteremia. It is also found in the adult population. The infection
involving the cortex will lift the periosteum thereby leading to the formation
of soft tissue abscess. After some time the abscess will lead to sinus tract
formation connecting the sequestrum to skin. Vertebral osteomyelitis is
becoming more common now-a-days due to intravenous drug use,increasing
life expectation and increased nosocomial infection.
CAUSATIVE ORGANISMS
The spectrum of microorganisms are variable according to the type of
Osteomyelitis, epidemiology, age of the patient, comorbidity, microbiological
technique and duration of infection. [17] Microbiological culture and
susceptibility testing should always be performed in order to optimize the
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antimicrobialtherapy.
In infants less than one year, Group B streptococci,Sstaphylococcus
aureus and Escherichia coli are the common organisms isolated. In children
aged 1 to 16 years S.aureus, Streptococcus pyogenes and Haemophilus
influenzae are the common causative organisms. In adults more than 16 years
Staphylococcus epidermidis, S.aureus, Pseudomonas aeruginosa, Serratia
marcescens and E.coli are the commonly isolated organisms.In acute
Osteomyelitis, over 50 % of clinical specimens contains a single organism. [18]
Common organisms isolated in specific condition
Community acquired methicillin resistant Staphylococcus aureus
(MRSA) is the important cause of acute osteomyelitis in children. [19] The
cytotoxin which is present in community acquired MRSA is Panton valentine
leucocidin (PVL).In children osteomyelitis due to PVL positive S.aureus
presents with more aggressive form with multifocal involvement when
compared with PVL negative S.aureus. [20] Common organisms in neonates are
group B Streptococci and Escherichia coli.Candida spp and Pseudomonas
aeruginosa are commonly encountered in IV drug abusers and patients with
indwelling catheters. Haemophilus influenzae type b, a common cause of
long bone osteomyelitis , has become rare due to the development and
widespread use of effective vaccine in children. [21]
CLINICAL FEATURES
In children, the early sign is pseudoparalysis(failure to move the
affected extremity) associated with fever and pain during passive movement
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ofthe affected limb.The signs of inflammation normally disappear within 5-7
days. Point tenderness is present if periosteum gets involved.
Neonates, when compared to other ages usually presents with non-
specific symptoms, resulting in delayed recognition and leading to serious
musculoskeletal sequelae [22]
DIAGNOSIS
Early diagnosis plays an important role in the management of
Osteomyelitis. In children, the diagnosis is made with compatible radiologic
and clinical findings with positive blood cultures. In adults, a CT-guided
aspirate or open biopsy is often necessary to establish a definitive diagnosis.
RADIOGRAPHIC FINDINGS
It is well known that the typical lytic and periosteal bone changes of
acute Osteomyelitis do not appear for 10 to 12 days following the onset of
illness [23]
TREATMENT
Appropriate antibiotics for adequate duration is the mainstay of
treatment for acute osteomyelitis. The principles of treatment proposed by
Nade are [24]
1)
2)
An appropriate antibiotic should be administered before the formation of pus.
Antibiotics cannot penetrate avascular tissues and abscesses ,so these
areas require surgical debridement.
3) Surgical treatment should
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not damage already
avascularbone and soft tissue.
4) Antibiotics should be continued even after surgical treatment.
Children are initially given parenteral therapy for 3-10 days .Then
appropriate oral therapy is chosen to provide high level of antibiotic
concentration which will help to eradicate the offending organism[25] .Oral
therapy with Cloxacillin and
penicillin in another study[26] .
Clindamycin were as effective as parenteral
COMPLICATIONS
In the preantibiotic era, 50 % mortality was seen in acute osteomyelitis
due to sepsis with metastatic abscesses. Today this is not the scenario.Acute
hematogenous S.aureus Osteomyelitis in children can lead to pathologic
fractures. This can occur in about 5 % of cases with a 72 day mean time from
disease onset to fracture. Other complications include Bone abscess,
Bacteremia, Septic arthritis, Chronic infection. [27] The percentage of children
developing chronic infection as a complication is 3-5%.
2. CHRONIC OSTEOMYELITIS
In Chronic Osteomyelitis, the common signs and symptoms are
bone loss and persistent drainage from sinus tracts. Cavities in the bone act as
the nidus for a persistent infection leading to a chronic condition. When the
original acute bone infection has subsided, it may persist as a low grade
infection subjected to repeated recrudescences of the acute process over many
months or years. The majority of cases of Chronic Osteomyelitis were as a
result of post traumatic infections due to compound fracture, crush injury,
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surgicalprocedures and diabetic infections of feet [28] .
EPIDEMIOLOGY
In the preantibiotic era, Osteomyelitis is associated with high
mortality ,which has come down after the advent of antibiotics. The incidence
of Chronic Osteomyelitis after compound fracture varies between 2% to
16%. This depends upon the grade of injury and the type of treatment given.
Now-a-days Chronic Osteomyelitis are due to trauma and surgery rather than
due to haematogenous spread.Osteomyelitis may be localized or may involve
the periosteum,cortex,marrow of the bone. The lower limb bones are
commonly involved. Nosocomial osteomyelitis is no longer rare.
PATHOGENESIS
Role of Microbes
The initial event which makes the infection to get localized is
adhesion. Staphylococcus aureus strains possess receptors for collagen,
fibrinogen, fibronectin, bone sialoprotein, and heparin sulphate [29] . Trauma or
injury will expose the binding sites for the organism. For Staphylococcus
aureus, the polysaccharide pseudocapsule forms strong links between the
bacterial cell and bone. The synthesis of capsule leads to the formation of
biofilm. In the biofilm, microcolonies are formed by bacteria that are
connected to each other and the surrounding environment. The glycocalyx
acts to protect the organism from host defense mechanisms and also from the
antibiotics[30] . Glycocalyx interferes with phagocytosis by connecting the
teichoic acid moiety which enhances opsonization and acts by consuming or
covering and altering the configuration of complement. Staphylococcus
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aureuscell wall contains protein A which functions as a virulence factor by
interfering with opsonization and ingestion of organisms by
polymorphonuclear cells, activating complement and eliciting immediate and
delayed hypersensitivity reactions.
Pathology
Sequestrum development is followed by reactive new bone (the
involucrum) formation by the periosteum around the sequestrum[31] .
In diabetics, if bone can be seen or probed through an ulcer there is
higher probability of underlying osteomyelitis. Bone biopsies from infections
that have spread to a bone from a contiguous focus or that are associated with
poor circulation especially in patients with diabetes are likely to yield
multiple isolates. [32]
CLINICAL FEATURES
The patient presents with pain, pyrexia, redness and tenderness which
have recurred or with a discharging sinus. Tissues are thickened and puckered
or folded in, where a scar or sinus is attached to the underlying bone [33] . In
post traumatic Osteomyelitis the bone may be deformed or ununited.
BACTERIOLOGY OF CHRONIC OSTEOMYELITIS
S.H.Sheely et al[34] states Staphylococcus aureus was most commonly
isolated followed
and
by gram negative
Other
bacilli,
organisms
Coagulase
are
negative
Staphylococcus Anaerobes. Pseudomonas,
Escherichia coli, Klebsiella and Proteus. Of all the gram negative organisms,
Klebsiella causes the most extensive bone destruction[31] .
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Proteusspecies can produce progressive, unrelenting, destructive
lesions of bone. Four types are involved. Proteus mirabilis is the most
common type. Salmonella osteomyelitis, a complication of typhoid fever is a
well recognized but uncommon clinical entity. It occurs in association with
sickle cell disease or other disorders of hemoglobin. It is characterized by
multiple bone involvement [35] . In patients with hematogenous osteomyelitis
the incidence of salmonella osteomyelitis is less than 1%. Salmonella typhi
and Salmonella paratyhpi B are the two strains most frequently implicated [36] .
Pseudomonas causing bacteremia either by the infection of contaminated
illicited drugs or as a result of infective endocarditis in the drug addict
population leads to vertebral osteomyelitis [37] . Vertebral osteomyelitis caused
by pseudomonas aeruginosa has also been reported in elderly persons
suffering from urinary tract infections [38] . Pseudomonas aeruginosa may also
involve the pubic symphysis in addicts. Brucella causes bone infection in 10%
of patients with brucellosis. The vertebrae are the common site involved.
A rare bacteria, Arcanobacterium hemolyticum[39] , in an apparent case
of tubercular osteomyelitis has been revealed. BCG vaccination
osteomyelitis [40] seems to occur in persons with apparently normal immunity.
In Anaerobic Osteomyelitis- anaerobic cocci were isolated more
frequently, and the most common of these was peptostreptococci. Bacteroides
species were the most frequently grown gram negative anaerobic organism[35]
with Bacteroides fragilis being the most common.
DIAGNOSIS
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Dueto lack of signs and symptoms, there is difficulty in diagnosing the
Chronic Osteomyelitis [41] . Reduced blood supply to the bone leads to slow
death of bone,which may lasts for years. Hence for diagnosing this disease,a
multidisciplinary approach is required, clinical examination, laboratory tests
and imaging studies. Due to chronic inflammation there is elevation of
Erythrocyte sedimentation rate.The leucocyte count is generally normal. The
C-reactive protein is elevated and non specific.Histopathological and
microbiological examination of the infected bone by obtaining a bone biopsy
specimen is considered as the gold standard for diagnosing this disease [42]
The material from drainage of abscess, discharging sinuses, curettage of
cavities and sequestrum should be obtained using swabs and processed for
identification of bacteria.
COLLECTION AND TRANSPORT OF SPECIMEN
The site of specimen collection should be thoroughly cleaned with
normal saline and then material is obtained from the depth of the sinus. The
swabs should be transported to the laboratory without delay. The swabs
should be transported in thioglycollate broth for anaerobic culture.
PROCESSING OF SPECIMENS
Microscopic examination
Smears should be made from the swab. Gram staining should be done
and examined under the microscope for the presence of epithelial cells, pus
cells, RBCs, bacteria and yeast cells. After inoculating on routine plating
media the samples should be inoculated in Lowenstein Jensen medium to
identify Mycobacterium tuberculosis. Specimens should be processed for
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anaerobicculture also.
Culture
The specimen should be inoculated on
1)
2)
3)
MacConkey agar plate
Blood agar plate
Chocolate agar plate
The plates should be incubated at 37°C aerobically for 24 hours. If
growth is observed, colony morphology and gram stain morphology are
studied.
The gram stain morphology showed gram positive cocci in clusters, the
following tests are done. Catalase test, coagulase test - slide & tube, ureàse
test and mannitol fermentation (aerobic and anerobic). Other special tests are
also done to confirm the organisms.
If gram negative bacilli are seen the colonies are subjected to the
following tests; catalase, oxidase, Hanging drop test for motility, citrate,
urease, triple sugar iron and sugar fermentation tests. Other special tests are
also done to confirm the organisms. The identification is done upto species
level. Antibiotic sensitivity should be performed for all isolates by Kirby
Bauer’s disc diffusion technique on Mueller Hinton agar. Sensitivity and
resistance pattern of the organisms are studied.
The use of 18-F fluorodeoxyglucose positron emission tomography
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imagingshowed a high degree of accuracy in diagnosing osteomyelitis. MRI
is more sensitive than CT in diagnosis. In certain circumstances, these
imaging modalities lack specificity. Due to their high sensitivities, they are
mostly used to rule out osteomyelitis.
In a non diabetic patient, bone biopsy for finding the causative
organism and its antimicrobial sensitivity pattern is taken if there are
radiographic changes in bone suggestive of osteomyelitis. Radiographic
changes may not revert even after the patient has started receiving
appropriate antibiotic therapy. Three- phase bone or to indium- labeled white
cell scan is done if the radiograph is normal and still there is suspicion of
osteomyelitis. In general CT scan and MRI are less frequently used to
diagnose osteomyelitis, but these are often used to determine the extent of
infection and whether these are collections of pus that are amenable to
drainage.The ‘gold standard’ specimen for diagnosing osteomyelitis is bone
biopsy specimen. Sinus tract cultures are not reliable for pedicting gram
negative organisms causing osteomyelitis [43] . In most cases antibiotic
treatment is based on culture from deep bone biopsies or debrided tissues
during surgery and their antibiotic susceptibilities. An earlier diagnosis of
osteomyelitis may be achieved with radio nucleotide scanning.
MANAGEMENT OF CHRONIC OSTEOMYELITIS
While antimicrobial therapy is desirable in the control of
Osteomyelitis, surgery remains the therapeutic and diagnostic procedure [6] .
Nelson et al states, administration of appropriate antibiotics for a
15
minimumof 3 weeks provides an
progression to chronic condition.
excellent response and there is no
Antimicrobial Therapy
Staphylococcus aureus is the common organism isolated. Vancomycin
is the drug of choice for the strains that are resistant to both ampicillin and
methicillin. Recently , Linezolid has evolved as a better drug against MRSA
because of its increased oral bioavailability and good bone
penetration.Prolonged use of linezolid has been associated with significant
pancytopenia, peripheral neuropathy, optic neuritis[44,45] . Daptomycin,
recently approved drug has bactericidal activity. Its utility in the treatment of
vancomycin resistant Enterococcus has yet to be defined.The period of
administration of antibiotics is 4 to 6 weeks.
Surgery
The surgery done for Chronic Osteomyelitis is Sequestrectomy and
removal of the infected bone and soft tissue. The goal of surgery is complete
eradication of every bit of an infection and thereby attaining a viable and vascular
environment. To achieve this goal, radical debridement may be required.
Inadequate debridement leads to recurrence. Simpson et al evaluated that the
recurrence rate is very low with wide resection (>5mm) than the patients treated
with marginal resection <5mm who had a 28% recurrence rate. The large dead
space which is left after adequate debridement, should be managed accordingly to
prevent recurrence and to avoid pathological fractures. Reconstruction of bone and
soft tissue defect is done after controlling the infection.
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Thewound is loosely packed open with petrolatum gauze and a
catheter is inserted for local application of antibiotics. If the bony defect is
large, the cavity is packed with small cancellous bone grafts mixed with an
antibiotic and a fibrin sealant (papineau et al (1979). The area is covered by
adjacent muscle and the skin wound is sutured without tension (Lack, Bosch
and Arbes, 1987). In muscle flap transfer, a large wad of muscle with intact
blood supply, is laid in the cavity and the surface is covered with split- skin
graft (Fitzgerald et al 1985) or Myocutaneous island flap (Yoshimura et al
1989). Recently, custom made calcium sulfate (osteoset bone voidfiller)
antibiotic impregnated implants[46] is used to treat chronic osteomyelitis.
In the study conducted by A.S. Bajaj and his colleagues mentioned above,
irrigation was done with appropriate antibiotics after culture and sensitivity report. It
was done for 4 to 14 days and successful in 73.3 percent of cases.
About 1000 to 1500 ml of irrigating fluid was used in 24 hours. The
returned fluid was cultured on 4th day and then daily. The irrigation was
continued till 2 consecutive cultures of the outflow fluid became negative.
Compere [47] (1967) has recommended the use of “Alevaire” for
irrigation of infection of bone and soft tissue for its mild antiseptic property
as well as for its action in making penicillin effective against penicillin
resistant organisms. However this last property of “Alevaire” has been refuted
in invitro studies (Modellering, treth and Weinburg 1971).
As an adjuvant therapy for chronic osteomyelitis, hyperbaric oxygen
therapy has been used frequently.
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COMPLICATIONS
Reduced rate of growth, pathologic fracture, bone lengthening, muscle
contracture, epithelioma and amyloidosis are the complications of chronic
osteomyelitis.
3. OTHER TYPES OF CHRONIC OSTEOMYELITIS IN
SPECIFIC CONDITIONS
a) Osteomyelitis in patients with Diabetes Mellitus or
insufficiency
Vascular
Patients with reduced vascular flow as in diabetes mellitus, are
predisposed to osteomyelitis due to poor local tissue response. 15% of
diabetes mellitus patients develop foot ulcers and 6% require hospitalization
for the same [48] . The development of a skin ulcer due to neuropathy, vascular
insufficiency
osteomyelitis.
Foot is the commonest site of infection[49] . There are several risk
factors which leads to the development of ulcers in the foot in diabetic
patients. All diabetic patients and patients with vascular compromise must
undergo complete foot examination every year.
and hyperglycemia subsequently leads to contiguous
Diagnosis
This requires multiple modalities and a careful examination of the foot.
A chronic ulcer with a surface area of more than 2cm2 or a positive “Probe-
to-bone test” [50] is associated with high positive predictive value.Also
complementary tests like measurement of ESR, C-reactive protein and MRI
should be done.
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Treatment
Broad spectrum antimicrobial therapy is required as most of these
infection are polymicrobial[3] . Quinolones in combination with metronidazole
or Clindamycin are used commonly for the treatment of osteomyelitis in
patient with diabetes and peripheral vascular disease [51] . Long-term safety of
fluoroquinolones has generally been good [15,48] . Latest generation quinolones
such as Moxifloxacin have excellent activity against gram-negative and gram
positive organisms and improved anaerobic activity. Depending on the level
of surgical debridement and amputation, the duration of antimicrobial therapy
varies from a few days to several weeks. Treatment for six weeks is
appropriate [51] .
b) Tuberculous osteomyelitis
About 10% of extrapulmonary tuberculosis affects bone. Tuberculosis
of spine contributes 50% of all skeletal tuberculosis cases. Most cases
occurred as the result of haematogenous spread from a pulmonary source. In
contrast to bacterial vertebral osteomyelitis systemic symptoms are absent.
Back pain or stiffness is the common symptom. The confirmation of diagnosis
is by biopsy result. CT and MRI are needed to know the extent of bony
involvement which is useful for planning the treatment. In
immunocompromised patients other non tuberculous Mycobacterial infection
is also common. Mycobacterium fortuitum, Mycobacterium chelonae,
Mycobacterium kansasii and Mycobacterium xenopi are known to cause
infections. Osteomyelitis due to Mycobacterium bovis after Bacille calmette-
Guerin (BCG) vaccination or intravesicular installation of Bacille calmette-
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Guerinhas been reported. Medical therapy alone is often curative. In certain
cases, surgical debridement is required.
c) Fungal osteomyelitis
Osteomyelitis resulting from fungi is uncommon. Several observational
studies and case reports have been published. Mode of spread is
haematogenous (67%), direct inoculation (25%) and contiguous infection
(9%) [52] . Bone lesions are most common in Blastomycosis, disseminated
Coccidioidomycosis and extracutaneous Sporotrichosis, but are seen
occasionally in Cryptococcosis, Candidiasis and Aspergillosis. Candida
Osteomyelitis is one of the less frequent manifestations of invasive
Candidiasis [53] . Candida albicans is the common species. Non albicans
Candida species account for 35% of cases [52] . Neonates and intravenous
heroin drug addicts are at risk to develop disseminated Candidiasis. In
adults,the order of frequency of involvement of bones is lumbar
spine [54] ,long bones and sternum. The diagnosis is confirmed by the isolation
of candida spp from the bone and histopathological confirmation. Most cases
resolve without surgery. Long term antifungal therapy is usually necessary.
Amphotericin B and Ketaconazole were used commonly. Fluconazole have
shown poor penetration to bone tissue.
d) Vertebral Osteomyelitis
Majority of the vertebral osteomyelitis are haematogenous in origin.
Haematogenous infection of the vertebrae spreads through segmental artery.
Haematogenous spread occurs via infection in skin and soft tissue,
genitourinary tract infection, infective endocarditis, infected vascular sites as
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wellas infection of respiratory tract. In one study by Schnoring and
Brock [55] , 0.2% of patient receiving antimicrobial prophylaxis developed a
surgical site infection, whereas 2.8% of patients developed surgical site
infection when antimicrobial prophylaxis was withheld. Infection of the disc
space and contiguous vertebra also can occur postoperatively.
The most common symptom and sign of vertebral osteomyelitis are
localized pain and spinal tenderness in 90% of patients.Due to nerve root
compression, motor and sensory deficits, are seen in 15% of patients.
An elevation of the ESR is present in more than 90% of cases, white
blood cell count is elevated in less than 50% of patient. If infective
endocarditis is present, blood cultures may be positive [56] .
As with other osteomyelitis, the most common micro organisms seen
in vertebral osteomyelitis are Staphylococcus aureus and Coagulase negative
Staphylococci . In endemic regions Mycobacterium tuberculosis is common.
In immunocompromised patients and postsurgical patients Aerobic
gramnegative bacteria and Candida spp are common.
Gram negative aerobic bacteria and Candida spp are seen more
commonly in IV drug abusers. Plain radiographs are not sensitive in the
diagnosis of disc space infection. In a study of 41 patients with suspected
spondylodiskitis, gallium scanning proved to be 100% sensitive, specific and
accurate [57] . CT- guided percutaneous biopsy has a sensitivity of 50% [58] .
The aim of treatment includes eradicating the infective foci which will
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relievepain and restore neurologic function and to maintain vertebral
stability. Surgical therapy is unnecessary, surgical treatment including
debridement should be considered in cases with paravertebral abscess. Wit h
appropriate antimicrobial medical treatment, spontaneous bony fusion
between adjacent infected vertebral bodies occurs within 12 to 24 months.
e) Osteomyelitis of the craniofacial skeleton
Osteomyeliltis of the skull is truly a bony infection which is due to
chronic, inadequately treated infections[59] . Van launelongue classified
osteomyelitis of skull as, primary hematogenous and secondary
contiguous [60] . Mandible, maxilla, frontal bone, temporal bone and skull base
bones [61] are commonly affected in this type of osteomyelitis. Severe
reduction of the blood flow leads to the formation of ischemic and necrotic
bone [62] . The usual organisms that can be isolated are Bacteroides,
microaerophilic Streptococcus spp, Peptostreptococcus, other odontogenic
pathogens which affect tooth bearing bone. For planning a complete
treatment, Bone scintigraphy is more ideal than CT. Clindamycin is the
ideal antibiotic due to its effectiveness against Streptococci and the
Anaerobes. As compared to other osteomyelitis, odontogenic infection should
be treated much longer times than usual for upto 6 months.
PREVENTION OF CHRONIC OSTEOMYELITIS
Osteomyelitis resulting from the haematogenous spread from the focus
of infection elsewhere in the body can be prevented by removing the infecting
focus. For example,if the infection is due to intravenous catheter,removal of
the catheter should be done and appropriate antimicrobial treatment should be
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givenfor 6 weeks.
Osteomyelitis following any surgery is also commonly occuring now-a-
days. Hence sterile aseptic surgical technique is essential for the prevention
of infection and its subsequent complications.
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AIMOF THE STUDY
 To study the predisposing factors associated with chronic
Osteomyelitis.
 To study the causative organisms and their antimicrobial susceptibility
pattern.
 To study the resistance pattern in common isolates.
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MATERIALSAND METHODS
PLACE OF STUDY
The study was conducted in the Institute of Microbiology, Madras
Medical College in association with Institute of Orthopaedics, Rajiv Gandhi
Government General Hospital, Chennai-600 003.
Name of the Study :
Period of Study
Sample Size
:
:
Cross Sectional
Oct 2011 to Sep 2012
120
Ethical Consideration
The necessary ethical committee approval was obtained before the
commencement of the study. Informed consent was obtained from the study
population. All patients satisfying the inclusion criteria were documented.
Patients were interviewed by structured questionnaire.
INCLUSION CRITERIA


Patients older than 12 years.
Patients admitted in orthopaedic wards and those attending outpatient
department who satisfy one of the following six components of chronic
osteomyelitis.


Osteomyelitis in association with trauma only.
Osteomyelitis in association with diabetes and peripheral vascular
compromise.
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



Clinical evidence of chronic disease. (Eg.Mycobacterium tuberculosis).
Radiological changes suggestive of infection for 6 weeks or more.
Formation of sequestrum or sclerosis.
Even after treatment, persistence or relapse of infection.
EXCLUSION CRITERIA


Patients with prosthetic orthopaedic implants devices.
Paediatric age group (<12 years)
HISTORY
Name, age, sex, date of admission, physical examination findings,
history of trauma, associated predisposing factor (diabetes mellitus,
intravenous drug abuse, immunosuppression, tuberculosis) duration of illness,
smoking and alcoholism were also recorded.
COLLECTION, TRANSPORT AND PROCESSING OF
SAMPLES [63]
Under strict aseptic precautions samples were collected from the
patients and transported immediately to the laboratory and sample processing
was done.
SAMPLES COLLECTED
1) Sequestrum and fragments of excised tissue removed during surgery or
curetting from infected sinuses.
2) Three swabs from the sinus tract- one for direct gram stain, acid fast
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stainand KOH mount. Second for aerobic bacterial and fungal culture.
Third for bedside inoculation into Robertsons cooked meat broth.
3) Pus.
COLLECTION OF SEQUESTRUM
Sequestrum obtained peroperatively were collected in a sterile
container without fixative. Fragments of excised tissue removed during
wound toilet or curetting from infected sinuses were also collected in a
similar manner. They were homogenized in a tissue grinder [32] with a little
sterile broth and subsequently treated in the same way as exudates.
COLLECTION OF SWABS
The surface of the wound was cleaned well with sterile normal saline
and swabs were taken from the depth of the sinus.
COLLECTION OF PUS
Pus was aspirated from the depth of the sinus or collected directly from
cavities per operatively and transported to the laboratory in a small screw-
capped bottle, syringe or a sealed capillary tube [64] .
PROCESSING OF SAMPLES
1) DIRECT SMEAR EXAMINATION
Using standard laboratory techniques, pus, exudates and swabs were
subjected to the following microscopic examination.
a. Gram stain: From all swabs, smears were prepared on clean glass
slides and were stained with Grams stain. Here the smear was flooded with
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methylviolet, waited for 1 min, washed with Grams iodine and allowed it to
act for 1 min. Then washed with water, acetone was added as a decolorizing
agent till no more color comes off, then washed with water and dilute carbol
fuchsin was added and allowed it to act for 1 min. Then washed with water,
blotted dry and examined under oil immersion objective. Presence of pus
cells, yeast cells, hyphal elements, Grams reaction, size and shape of
organisms were noted.
b. 10% potassium hydroxide mount [65]
A clean glass slide was taken and a large drop of KOH was placed with a
pasteur pipette. A small quantity of the sample was transferred with the loop
into the KOH drop. A clean cover slip was placed over the drop gently
without producing air bubbles. The slide was kept at room temperature. After
20 to 30 minutes the slide was examined under microscope. Necrotic bone and
tissues were allowed for overnight contact with KOH and examined on the
next day.
c. Acid fast stain by Ziehl- Neelsens method [64]
Procedure
i.
ii.
Place heat fixed smear on a staining rack.
Filter strong carbol fuchsin on to the slide through a whatman
No.1 filter paper.
iii. Soak a cotton-wool swab attached to a wire in methylated
spirits.
iv. Ignite the swab in
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the Bunsen flame
anduse to heat the slide without boiling so that they steam,
leave for 3 min.
v.
vi.
vii.
viii.
ix.
x.
xi.
xii.
Repeat steps 3 and 4.
Gently wash with tap water.
Decolourize with 3% acid alcohol for 3 min.
Gently wash with tap water.
Decolourize with 20% sulphuric acid for 5 min.
Wash, repeat steps 9 and 10.
Counterstain with loeffler’s methylene blue for 30 seconds.
Wash & Examine under oil immersion objective.
2) CULTURE
The samples were plated onto the following media. 5% Sheep blood
agar, Chocolate agar, Mac conkey agar, Cooked-meat broth and Sabouraud’s
dextrose agar. All the inoculated plates except cooked meat broth were
incubated at 37 0 C under aerobic condition and in a carbondioxide enriched
atmosphere. Plates were evaluated for growth at 24 and 48 hours and
discarded after five days except Sabouraud dextrose agar which was kept for
4 weeks. Cooked meat broth was incubated at 37 0 C with sterile liquid paraffin
and looked for turbidity after 24 and 48 hours. If any turbidity was found in
cooked meat broth, it was subcultured in Gentamycin blood agar and
incubated anaerobically in gaspak at 37 0 C. These anaerobic plates were
examined after 72 hrs of incubation.
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3.INTERPRETATION
A) INTERPRETATION OF BACTERIAL CULTURES
1480-CHARTS]
[63,P-1443-
I. After 24 hours of incubation, identification of bacteria was done by
studying morphology of colony, gram stain, motility, catalase and
oxidase tests. Single colony was taken and subjected to a battery of
tests along with the controls.












Gram staining
Hanging drop
Oxidase test
Catalase test
Coagulase test
Phosphatase test
Bile esculin hydrolysis
IMVIC test
Nitrate reduction test
Urease test
TSI (Triple sugar iron agar)
Phenyl alanine deaminase test
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


O-F test
Sugar fermentation test
LAO decarboxylases test
Oxidase test
1% tetramethyl - p - phenylene diamine dihydrochloride was prepared
freshly with sterile distilled water. A filter paper circle was placed into a
sterile petridish and moistened with several drops of the fresh reagent. A
colony from a nutrient agar was removed with a sterile glass rod and rubbed
onto the moistened filter paper along with controls. Appearance of dark
purple color within 10 sec was considered as positive.
Catalase Test
Single colony from nutrient agar plate was picked with a sterile glass
rod and inserted into 1ml of 3% hydrogen peroxide solution in a small clean
test tube. Immediate and sustained production of gas bubbles from the colony
indicate positive reaction.
Coagulase Test
This was done to detect both free and bound coagulase enzymes.
Slide coagulase test
Slide test is a rapid test to detect bound coagülase. Two drops of
normal saline were placed in two circles drawn on a glass slide. Growth was
taken from nutrient agar plate and emulsified into smooth suspension in two
circles. Then one drop of undiluted plasma was added to one circle which was
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markedas test and the other circle as control without plasma. Visible
clumping within 10 - 15 sec. of mixing the plasma with the suspension was
taken as positive.
Tube coagulase test
This test detects free coagulase. A small amount of the colony growth
of the organism is emulsified with 0.5ml of coagulase plasma. The tube is
incubated at 35 0 C for 4 hours and observed for clot formation by gently
tilting the tube. If no clot is observed at that time, reincubate the tube at room
temperature and read again after 18 hours.
Indole Test
Organisms were suspended into Tryptophan broth and incubated at
37°C for 18-24 hrs. 15 drops of Kovac’s reagent was added along the inner
wall of the tube. Appearance of red ring over the surface was taken as
positive.
Methyl red test
Organisms were suspended into Glucose Phosphate broth and incubated
at 37°C for 48-72hrs. Then 5 drops of MR reagent was added to the broth.
Appearance of red color indicated positive result.
Voges-Proskauer Test
Organisms were inoculated into Glucose Phosphate broth and
incubated at 37°C for 48-72 hrs. Then 0.6m1 of 5% a naphthol was added,
followed by 0.2ml of 40% KOH. The tube was gently shaken without cotton
plug to expose the medium to atmospheric oxygen and was read after 10-15
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minutes.Development of red color within 15 min. was taken as positive.
Citrate utilization test
This test is done to check the ability of an organism to use citrate as its
whole source of carbon and energy source for growth and ammonium as
nitrogen source. A saline suspension of the test organism is streaked in
simmon’s citrate medium and incubated for 48 hrs at 37 0 c.
Blue colour and streak of growth=positive.
Original green colour and no growth=negative.
Nitrate reduction test
Nitrate broth was suspended with organisms to be tested and incubated
at 37°C for 24 - 48 hrs. 5 drops of each reagent A(α naphthylamine) and
reagent B (sulfanilic acid) were added to the broth. Red color developed
within few minutes indicate the presence of nitrite i.e the positive reaction.
Urease test
The entire slope of the Christensen’s medium was streaked with test
organisms and incubated at 37°C for 24 - 96 hrs. Urease producing organisms
changed the color of medium to purple pink.
Sugar fermentation tests
Sugar fermentation test media containing different sugars in the
concentration of 1%, with inverted Durham’s tubes were suspended with test
organisms, and incubated at 37°C and observed for up to 1 week. Change of
color to yellow was considered as positive (sugar was fermented). Presence of gas
in Durham’s tubes indicated gas production.
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O-Ftest
Two tubes of Hugh - Leifsons test media were stab inoculated with
test organisms. One tube of this pair was covered with a 1cm layer of liquid
paraffin and the other tube was left open to air. Both tubes were incubated at
37°C and examined daily for up to 7 days. Appearance of yellow color in
open tube and green color in covered tube, indicated oxidative utilization of
the sugar.
Triple Sugar Iron test
The organism was stabbed into butt and streaked onto the surface of
slant, incubated at 37°C overnight. The next day change of color, H 2 S
production and presence of gas were noted.
Phenyl alanine deaminase test
The medium containing phenyl alanine deaminase was suspended
heavily with organism to be tested and incubated at 37°C overnight. Next day
few drops of 10% solution of ferric chloride was allowed to run down over
the growth. Appearance of apple green color in the slope indicated positive
test.
Phosphatase test
Organism was grown on phenolphthalein diphosphate agar (consist of
l000ml of nutrient agar and l0ml of 1% aqueous solution of sodium
phenolphthalein diphosphate) at 37°C overnight. Next day few drops of liquor
ammonia was poured on lid and plate was inverted over the lid. Colonies
turned to bright pink, from yellow color within a few minutes, due to
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liberationof free phenolphthalein by the action of phosphatase. This
considered as positive.
was
Bile Esculin Hydrolysis
Organism was streaked on the surface of bile esculin slant and
incubated over night. If the organism hydrolyses bile esculin ,slant would be
turned black. This test was used to confirm gram positive cocci in pairs as
Enterococci.
LAO Decarboxylases Test
This test is based on the ability of bacteria to decarboxylate an
aminoacid to the corresponding amine with liberation of carbondioxide. The
production of decarboxylases is induced by a low pH which occurred due to
fermentation of glucose and as a result of the action of decarboxylases ,the pH
is raised due to the production of amines. The medium was inoculated with a
straight wire through the paraffin layer .Incubated and read daily for 4 days.
Appearance of violet colour indicate positive test.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Antibiotic susceptibility testing was performed by the Kirby bauer
method on Mueller Hinton agar (Himedia) according to CLSI guidelines[66] .
The diameters of zones of inhibition were interpreted according to CLSI
standards for each organism. Media and discs were tested for quality control
using standard strains.
The following standard strains were used
1) Staphylococcus aureus- ATCC 25923
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2)
3)
Escherichia coli- ATCC 25922
Pseudomonas aeruginosa- ATCC 27853
For gram positive cocci, the following antibiotics were included in the
antimicrobial sensitivity testing (Himedia)
Inhibition Zone in mm
Antibiotic Disc content
Resistance
Amikacin
Ciprofloxacin
Cotrimoxazole
Chloramphenicol
Penicillin
Rifampin
Erythromycin
Oxacillin
30g
5g
1.25-23.75g
30g
10 Units
5g
15g
1g
14
15
10
12
28
16
13
10
Intermediate
15-16
16-20
11-15
13-17
–
17-19
14-22
11-12
Sensitive
17
21
16
18
29
20
23
13
For gram negative bacilli, the following antibiotics were included in
the antimicrobial sensitivit y testing (Himedia)
36
InhibitionZone in mm
Antibiotic Disc content
Resistance
Amikacin
Ceftazidime
Cefotaxime
Ciprofloxacin
Gentamicin
Imipenem
Ofloxacin
Tetracycline
Piperacillin/
Tazobactum
30g
30g
30g
5g
10g
10g
5g
30µg
100/10g
14
14
14
15
12
13
12
14
17
Intermediate
15-16
15-17
15-17
16-20
13-14
14-15
13-15
15-18
18-20
Sensitive
17
18
18
21
15
16
16
19
21
Procedure of Kirby-Bauer Disc Diffusion Test
1) With a wire or a loop touched the surface of 5 similarly appearing
colonies on an agar plate culture. Transferred the growth to a tube
containing a suitable broth medium.
2) Allowed the culture to incubate at 35 0 C until it matches the turbidity of
standard.
3) Dipped a sterile non-toxic cotton swab into the inoculum suspension
and rotated the swab several times with firm pressure on the inside
wall of the tube to remove excess of fluid.
4) Inoculated the dried surface of a Mueller Hinton agar plate that has
been brought to room temperature by streaking the swab 3 times over
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theentire agar surface rotating the plate approximately 60 degrees to
ensure an even distribution. Replaced the lid of the dish. Allowed 3 to
5 minutes but no longer than 15 minutes for the surface of the agar to
dry before adding the antibiotic discs.
5) Appropriate antimicrobial disc was placed on the surface of the agar
using forceps.
6)
7)
Plate was incubated at 37 0 c overnight.
After overnight incubation, zone diameters was measured in mm from
the edge of the disc to the zone edge with a ruled template on the agar surface
DETECTION OF  LACTAMASE ENZYMES IN GRAM NEGATIVE
BACILLI
Extended spectrum lactamases (ESBL’s)
ESBL’s are classified under in Bush class A  lactamases which are
capable of hydrolyzing penicillins- oxyiminocephalosporins and
monobactams (Aztreonam) and inhibited by  lactamase inhibitors (clavulanic
acid, sulbactum and Tazobactum) but have no detectable activity against
cephamycins or carbapenems (Imipenem, Meropenem).
ESBL Detection methods
Screening Method [67]]
Antibiotic
Aztreonam 30g
Cefotaxime 30g
Ceftazidime 30g
Ceftriaxone 30g
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For Possible ESBL Producing Stains
< 27mm
< 27 mm
<22 mm
< 25mm
DoubleDisk diffusion synergy test
24 hour young culture was used for this test. 3 to 4 colonies from 24 hr
culture were inoculated into 5 ml of nutrient broth to match 0.5 Macfarland
turbidity standard. Lawn culture of the test organism should be made on MHA
plate. Two discs Ceftazidime and Ceftazidime in combination with clavulanic
acid were placed. The plate is incubated at 350 C for 16-18 hours.
Interpretation
A >5mm increase in zone diameter for either antimicrobial agent tested
in combination with clavulanic acid versus its zone when tested alone
confirms an ESBL producing organism[68,66] .
Phenotypic confirmatory double disk test (PCDDT)
In this method a lawn culture of test organism on to a MHA plate was
performed. Augmentin disc was placed in the centre of the plate and a disk
containing one of the oxyimino  lactam antibiotics was placed 30mm from
centre to centre from augmentin disk. The test organism was considered to
produced ESBL, if the zone size around the test antibiotic disc increased
towards the augmentin disk [69] .
The sensitivity of the test could be increased by reducing the distance
between the disc to 15mm or 20mm, also by using more than one oxyimino 
lactam antibiotic.
ESBL detection by E test strip
This combines both the principles of dilution and diffusion techniques.
E strip is a thin non porous plastic strip 5mm wide and 60mm long. It carries
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twoshorter gradients aligned in opposing directions on a single strip. One end
generates a stable concentration gradient of the one of the oxyimino
cephalosporins (eg ceftazidime), while the other end generates a gradient of
cephalosporin + clavulanic acid (4g/ml). When applied to an inoculated agar
plate inhibition ellipse may be seen on the both ends of the strip. MIC is
interpreted as the point of intersection of the inhibition ellipse with E test
strip edge. Ratio of cephalosporin MIC and cephalosporin clavulanic acid
MIC >8 indicates positive result.
DETECTION OF METHICILLIN RESISTANCE IN
STAPHYLOCOCCUS AUREUS
Disc diffusion Method
Media- MHA
Antibiotic disc- Cefoxitin disks 30g
QC Strain – ATCC S.aureus 25923 was used.
Procedure
Inoculum Preparation
Colonies isolated from agar culture plate were suspended directly into
broth or physiological saline (0.85% Nacl, vortexed to reach 0.5 McFarland
(10 8 CFU/ml).
A lawn culture of the Staphylococcus aureus was made on the MHA
plate and the cefoxitin disks(30µg) were applied.
Incubated at 35 0 C for 24 hrs in an ambient air.
The diameter of the zone of inhibition around the discs was measured.
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2C-S4]
According to CLSI criteria,2011,with 30µg cefoxitin disks [70,66 -supp
,
Diameters of <21mm= Resistant to oxacillin(MRSA)
>22mm = Susceptible to oxacillin(MSSA).
No intermediate category.
ta b-
DETERMINATION OF MIC
The following are the different methods of detecting MIC of an
antibiotic against a specific bacterial isolate.
1) Broth dilution method
a) Macrobroth method
b) Microbroth method
2)
3)
4)
Agar dilution method
Using E strip
Using Hi-comb method
MIC of vancomycin against Staphylococcus aureus was determined by
Macro Broth dilution method.
MIC of cefotaxime against Klebsiella pneumoniae was determined
using Hi-Comb method.
Procedure of Hi-comb method
A lawn culture of the test organism was made on a MHA plate Hi-
Comb Strips were applied with the MIC scale facing upward. The strip should
be in complete contact with the agar surface. The agar plate was inverted and
incubated at 35 0 C for 24hrs. The method combines the principle of dilution
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anddiffusion. The E test MIC was read where the edge of the inhibition
ellipse intersects the MIC scale on the strip
Minimum Inhibitory Concentration (MIC) for detecting vancomycin
resistance
1)
2)
Cation adjusted Mueller Hinton Broth (PH 7.2-7.4) was used.
Preparation of stock antibiotic solution [71]
Antibiotic stock solution was prepared using the formula.
1000
------- x V x C = W
P
Where P= Potency of the antibiotic in relation to the base (For
vancomycin, P= 950/1000mg Himedia).
V = Volume of the stock solution to be prepared (10ml).
C = Final concentration of the antibiotic solution (1024 g/ml).
W = Weight of the antibiotic to be dissolved in the volume V.
3) Method of preparing dilution of antibiotics
 Sterile test tubes were arranged in two rows in the rack (1 row for the
test and another one is for ATCC control).
 Transferred 2ml of MH broth to the sterile container containing the
working stock solution (128 g/ml concentration). From this 1ml was
transferred to the first tube in each row.
 2ml of MH broth was added to the 2ml of the diluted antibiotic in the
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sterilecontainer, mixed well and 1ml was transferred to second tube in
each row.


Repeated this procedure till the 8 th tube.
One ml of the antibiotic was kept for control.
4) Inoculum preparation for the test and ATCCcontrol



9.9ml of MH broth was taken in a sterile container.
0.1ml of 0.5 Mcfarland tubidity matched test organism was added.
After mixing well, 1ml of inoculum was transferred to each tube
containing antibiotic dilutions and also to the control tube.
 The procedure was repeated for ATCC control stain.
The tubes were incubated at 37 0 C for 16-18 hrs. After 16-18 hrs, the
tubes were taken out and MIC was read. The lowest concentration of the
antibiotic in which there is no visible growth was taken as MIC of
Vancomycin for the test organism. The above procedure was repeated for
ATCC S.aureus, and MIC was interpreted.
B.INTERPRETATION OF FUNGAL CULTURE
Samples were inoculated onto two SDA slants and were incubated at
two different temperatures, 25 0 C and 35 0 C. These slants were inspected daily
during the first week and twice weekly during the next three weeks for
growth.
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MacroscopicAppearance
Cream colored, smooth or wrinkled with mycelial fringe and pasty
colonies within 3-4 days.
Microscopy
Gram stain and LCB mount were prepared from the colonies.
Gram Stain Gram positive ovoid budding yeast cells approximately 4-
8 m in size with pseudohyphae is suggestive of candida spp.
LCB Presence of yeast cells and pseudohyphae.
Germ tube test [65]
Germ tube test is used for presumptive identification of Candida
albicans. It is a rapid screening test where the production of germ tubes with
in two hours is considered as growth of Candida albicans.
Make a very light suspension of the test organism in 0.5ml of sterile
serum (pooled human serum or fetal calf serum). The optimum inoculum is
10 5 -10 6 cells per ml. Incubate at 37 0 C for exactly two hours. Observed under
microscope for production of germ tube. Germ tubes represent initiation of
hyphal growth, arising directly from the yeast cell. They have parallel walls at
their point of origin and are not constricted. To record a positive, about 30%
of the cells should show germ tube production.
Chrom Agar Media [72]
It is a rapid, plate based test for the simultaneous isolation and
identification of various Candida species. These media are based on direct
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detectionof specific enzymatic activities by adding multiple chemical dyes
i.e. substrates of fluorochromes to media. Candida species are differentiated
by color as a result of biochemical reactions.
The CHROM agar media shows following colors of colories at 30 0 C
for 48 to 72 hours.
C.albicans
C.dubliniensis
C.glabrata
C.krusei
C.parapsilosis
C.tropicalis
Light Green
Dark Green
Pink to Purple
Pink
Cream to Pale Pink
Blue with Pink halo
Sugar fermentation
Biochemical tests like sugar fermentation was done for identification
of yeast isolate. Glucose, Maltose, sucrose, Lactose, Galactose and Trehalose
sugars (2%) were used.
Determination of MIC by microbroth dilution method [65]
As per the guidelines of CLSI, the test was performed. MIC of water
soluble drug Fluconazole and water insoluble drugs Amphotericin-B,
Itraconazole and Voriconazole were determined.
The test consisted of following steps
1. Preparation of antifungal stock solutions.
45
2.Preparation of inoculum.
3. Test procedure.
For water insoluble drugs, dimethyl sulfoxides (DMSO) was the
solvent used.
Media used- RPMI 1640. Varying concentrations of the drugs were tested.
Amphotericin B
Fluconazole
Itraconazole and Voriconazole
Incubation period – 48 hours.
ATCC candida albicans ATCC 90028 was used for quality control of
the test. The broth microdilution test was performed by using sterile,
disposable, multiwell microdilution plates (96U- shaped wells). 100l of
varying drug concentrations was dispensed in each rows from 1 to 10. 100l
of inoculum was also dispensed. Incubated at 35 0 C for 48 hours. MIC was
interpreted, as the lowest concentration in which the well was clear in case of
Amphotericin B. For Azoles, it was interpreted as the lowest concentration in
which there was a prominent decrease in turbidity (50% inhibition in growth
as determined spectrophotometrically).
0.0313 to 16g/ml
0.125 to 64g/ml
0.0313 to 16g/ml
C.CULTURE FOR MYCOBACTERIUM TUBERCULOSIS
All the samples were screened for the presence of acid fast bacilli by
Ziehl Neelsen method of acid fast staining. Few samples were sent to
Tuberculosis Research Centre, Chetpet for culture and sensitivity.
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RESULTS
This study was conducted in the Institute of Microbiology in
association with the Institute of Orthopaedics, Rajiv Gandhi Government
General Hospital, Chennai-600 003.
TABLE-1: AGE AND SEX DISTRIBUTION
Age (Years)
<20
21-30
31-40
41-50
51-60
61-70
Chi square: 4.471
No. of Patients
Male n =97Female n =23
18 (18.5%)5 (21.7%)
21 (21.6%)7 (30.4%)
25 (25.7%)5 (21.7%)
18 (18.5%)2 (8.6%)
9 (9.2%)4 (17.3%)
6 (6.1%)0
Total n =120
23 (19.1%)
28 (23.3%)
30 (25%)
20 (16.6%)
13 (10.8%)
6 (5%)
p= 0.484 [not significant]. The mean age of male
is 35.94. The mean age of female is 31.78. Out of 120 patients, 30 patients
belonged to age group 31-40 years (25% of total cases), 28 patients belonged to
the age group 21-30 years (23% of total cases). In all age groups, males were
commonly affected because they were more prone to accidents than females as
they do outdoor work, construction work and high altitude work. In this study,
97 were males and 23 were females.
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TABLE-2:DURATION OF ILLNESS
Duration in Months
2-6
7-12
13-24
25-36
No. of Patients n =120
19
48
43
10
Percentage
15.8
40
35.8
8.3
Most patients (40%) had duration of illness between 7-12 months. This
was followed by the patients (35.8%) who had duration of illness between13-
24 months.
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TABLE-3:CORRELATION OF SEX AND DURATION OF
ILLNESS
SEX
DURATION
ACTUAL
MONTHS
The
M
F
n
97
2
Mean
14.03
13.00
illness
Std.Std. Error Significance
Deviation of mean
7.555
9.200
in males
.767
1.918
is 14.03.P=0.574[not
P=0.574
mean duration of
significant]. The mean duration of illness in females is 13.00.
CORRELATION OF SEX AND DURATION OF ILLNESS
120
100
80
60
40
20
0
Male
No. of Patients Mean
Female
14.03
2
13
97
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TABLE-4:CORRELATION OF AGE AND DURATION OF
ILLNESS
Groups
1
2
3
4
Total
n
19
48
43
10
120
Mean
29.47
30.33
39.02
52.30
35.14
Std. Deviation
16.473
10.041
15.056
12.962
14.772
Groups :1-duration of illness 2-6 months
2-duration of illness 7-12 months
3-duration of illness 13-24 months
4-duration of illness 25-36 months.
P = 0.000<0.001 . The mean age level in the duration of illness
is statistically significant. Among the duration of illness, group with largest
duration had age mean level as 52.30 , which is significantly an elevated
age mean level than other duration group.
CORRELATION OF AGE AND DURATION OF ILLNESS
100
80
60
40
20
0
1 2
No. of Patients
3
Mean
4
29.47
48
19
43
10
52.3
30.33 39.02
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TABLE-5:PREDISPOSING FACTORS
Duration in Months
Compound fracture due to
road side accidents
Post Surgical
Diabetes mellitus with
vascular insufficiency
Smoking/ Alcoholism
Haematogenous
LowerUpper
No. of
Patients Percentage confidence confidence
limits inlimits in
n =120
percentage percentage61
24
17
13
5
50.8%
20.1%
14.1%
10.8%
4.1%
41.92
13.25
8.474
5.896
1.366
59.71
28.28
21.71
17.81
9.456
Among 120 cases of chronic osteomyelitis, 61 patients developed
the infection as a result of compound fracture due to road side accidents and
trauma (50.8%). 24 cases (20.1%) were due to post surgical wounds. 17 cases
(14.1%) had diabetes mellitus as the predisposing factor. 13 cases (10.8%)
had smoking/ alcoholism as the predisposing factor. 5 patients (4.1%)
acquired the infection of bone due to haematogenous spread of organisms.
51
TABLE-6:SITE OF INFECTION
Bone
Tibia
Femur
Metatarsal
Humerus
Calcaneum
Dorsal Spine
Frontal Bone
Fibula
Radius
Rib
Sacrum
Sternum
Maxilla
Clavicle
Femur /Tibia
Total
No. of Patients
n =120
53
33
6
5
4
3
3
2
2
2
2
2
1
1
1
120
Male
n =97
43
24
6
5
4
2
1
2
2
2
2
2
1
1
1
97
Female
n =23
10
9
0
0
0
1
2
0
0
0
0
0
0
1
0
23
Percentage
44.2
27.5
5
4.1
3.3
2.5
2.5
1.6
1.6
1.6
1.6
1.6
0.8
0.8
0.8
100
p= 0.545 . No statistical significance was found between the male and
female with respect to different bone sites.
The commonest bone infected was tibia in 53 patients (44%), out of
which 43 were males and 10 were females. Femur was the second common
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boneinfected in 33 patients (29%). Out of 33,24 were males and 9 were
females. Other bones of lower extremities like metatarsals, calcaneum and
fibula were affected in the order of 6 patients (5%), 4 patients (4%) and 2
patients (2%) respectively. Only males got infected in these bones. Bones of
the upper extremities like Humerus and Radius were infected in 5 patients
(4.1%) and 2 patients (1.66%) respectively. They were males. 3 patients
developed infection in frontal bone. Among them 2 were females and one was
male. One male patient had infection in maxilla. Bones of the axial skeleton
like thoracic vertebrae, sacrum, sternum and clavicle were involved in 3
patients (2.5%), 2 (1.66%), 2 (1.66%), and 1 (0.8%) respectively. Out of 3
patients who got infected in thoracic vertebrae 2 were male and one was
female. Only males were affected with the involvement of sacrum, sternum
and clavicle.
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TABLE-7-SITEOF BONE*AGE GROUP
CROSSTABULATION
Age Group
1
CALCANEUM
CLAVICLE
DORSALSPINE
FEMUR
FEMUR/TIBIA
FIBULA
FRONTAL BONE
HUMERUS
MAXILLA
METATARSAL
RADIUS
RIB
SACRUM
SKULL
0
.0%
0
.0%
0
.0%
10
8.3%
0
.0%
0
.0%
0
.0%
0
.0%
0
.0%
1
.8%
1
.8%
0
.0%
0
.0%
0
2
2
1.7%
0
.0%
2
1.7%
7
5.8%
0
.0%
0
.0%
0
.0%
3
2.5%
0
.0%
0
.0%
1
.8%
1
.8%
0
.0%
1
3
1
.8%
0
.0%
0
.0%
10
8.3%
0
.0%
2
1.7%
0
.0%
1
.8%
0
.0%
2
1.7%
0
.0%
0
.0%
2
1.7%
1
4
1
.8%
0
.0%
0
.0%
3
2.5%
1
.8%
0
.0%
1
.8%
1
.8%
1
.8%
0
.0%
0
.0%
0
.0%
0
.0%
0
5
0
.0%
1
.8%
0
.0%
2
1.7%
0
.0%
0
.0%
0
.0%
0
.0%
0
.0%
1
.8%
0
.0%
0
.0%
0
.0%
0
6
0
.0%
0
.0%
0
.0%
1
.8%
0
.0%
0
.0%
0
.0%
0
.0%
0
.0%
2
1.7%
0
.0%
1
.8%
0
.0%
0
Total
4
3.3%
1
.8%
2
1.7%
33
27.5%
1
.8%
2
1.7%
1
.8%
5
4.1%
1
.8%
6
5.0%
2
1.7%
2
1.7%
2
1.7%
2
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AgeGroup
1
.0%
SPINE
STERNUM
TIBIA
Total
0
.0%
0
.0%
11
9.2%
23
2
.8%
1
.8%
0
.0%
10
8.3%
28
3
.8%
0
.0%
0
.0%
11
9.2%
30
4
.0%
0
.0%
2
1.7%
10
8.3%
20
5
.0%
0
.0%
0
.0%
9
7.5%
13
6
.0%
0
.0%
0
.0%
2
1.7%
6
Total
1.7%
1
.8%
2
1.7%
53
44.2%
120
19.2% 23.3% 25.0% 16.7% 10.8% 5.0% 100.0%
p= 0.140. There is no statistical significance exists among different
age groups with respect to the bone site.
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TABLE-8:SAMPLES COLLECTED FROM THE STUDY
GROUP
Samples
Discharge from sinus
Sequestrum
Intraoperative collection
of pus/tissue fluids
Number
n=120
57
41
22
LCL inUCL in
Percentage percentage percentage
47.5
34
18.3
38.31
25.76
11.86
56.82
43.38
26.43
LCL - lower confidence limit, UCL-upper confidence limit
From the above table, it was found that 57 patients (47.5%) had discharge
from sinuses as the presenting symptom. The other patients had pain, low
grade fever and swelling as the presenting symptoms. Among the samples
collected from them, 57 were collected as discharge from sinuses, 41 (34.1%)
as sequestrum and 22 (18.3%) as intraoperative collection of pus.
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TABLE-9:CULTURE POSITIVITY
Culture Number
Percentage
n =120
Positive
No Growth
100
20
83.3
16.6
Lower
confidence
limit in
percentage
75.44
10.49
Upper
confidence
limit in
percentage
89.51
24.56
Among 120 cases studied, culture positivity was seen in 100 patients
(83.3%). Out of 100, 92 (76.6%) were grown as pure culture (monomicrobial).
9 (7.5%) showed mixed growth (polymicrobial), 20 (16.6%) showed no
growth.
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TABLE-10:CORRELATION BETWEEN TYPE OF
SPECIMEN COLLECTED AND TYPE OF PATHOGENS
ISOLATED
Type of
Pathogen
Monomicrobial
Polymicrobial
No Growth
Swab
n=57
33(57.8%)
7 (12.2%)
17(29.8%)
Sequestrum/ Intraoperative
collection of pus and tissue fluids
n=63
59(93.6%)
1(1.5%)
3(4.7%)
Total
n=120
92
8
20
Chi-square: 21.4 P= 0.0000253<0.0001 significant.
Polymicrobial growth was seen more in swabs when compared to sequestrum
and intraoperative collections. Hence sequestrum or intraoperative collections are the
ideal samples for culture.p value also showed statistical significance.
Pathogens isolated were monomicrobial in 92 cases, polymicrobial in 8
cases. Of the 63 sequestrum/ intraoperative collection of pus and fluids, 59
were monomicrobial and only one was polymicrobial. Mycobacterium
tuberculosis and Candida tropicalis were isolated only from sequestrum
samples. Of the 57 swabs, 33 were monomicrobial 7 were polymicrobial.
Though monomicrobial infection was the commonest type in both samples, an
increased number of polymicrobial infection was noted only in swabs.
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TABLE-11:ORGANISMS ISOLATED IN CHRONIC
OSTEOMYELITIS
Organisms Number
Aerobic bacterial isolates n =106
Gram Positive Cocci
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus schleiferi
Staphylococcus saprophyticus
Staphylococcus lugdunensis
Staphylococcus warneri
Enterococcus fecalis
Gram Negative Bacilli
Pseudomonas aeruginosa
Proteus mirabilis
Klebsiella pneumoniae
Escherichia coli
Acinetobacter baumanii
Acid fast bacilli n=1
Mycobacterium tuberculosis
Fungal n=1
Candida tropicalis 1 1.08
1 1.08
17
10
9
6
4
16
9.4
8.4
5.6
3.7
39
11
3
2
2
2
1
36.7
10.3
2.8
1.8
1.8
1.8
1
Percentage
The above table shows, 56.6% of isolation of GPC, 43.3% of isolation of
GNB, one acid fast bacillus Mycobacterium tuberculosis and one yeast
Candida tropicalis was also isolated in this study.
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ORAGANISMS ISOLATED IN CHRONIC OSTEOMYELITIS
GRAM POSITIVE COCCI
39
40
35
30
25
20
15
10
 5
 0
18
16
14
12
10
 8
 6
 4
 2
 0
17
GRAM NEGATIVE BACILLI
10 9
6
411
3 2 2 2 1
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TABLE-12:COMBINATION OF BACTERIAL ISOLATES IN
MIXED INFECTIONS
Organisms
Staphylococcus aureus and Pseudomonas
aeruginosa
Staphylococcus schleiferi and Enterococcus
fecalis
Staphylococcus epidermidis and Klebsiella
Pneumoniae
Proteus mirabilis and Escherichia coli
3
1
1
3
No of
patients
n=8
Percentage
37.5%
12.5%
12.5%
37.5%
Staphylococcus aureus ,Pseudomonas aeruginosa, Proteus mirabilis,
Escherichia coli were commonly isolated in mixed infections.3 out of 39
isolates of Staphylococcus aureus,3 out of 17 isolates of Pseudomonas
aeruginosa,3 out of 10 isolates of Proteus mirabilis,3 out of 6 isolates of
Escherichia coli were isolated in mixed infections.one out of 11 isolates of
S.epidermidis,1 out of 3 isolates of S.schleiferi and 1 out of 9 isolates of
Klebsiella pneumoniae were also isolated in mixed infections.
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TABLE-13:ANTIMICROBIAL SENSITIVITY PATTERNS OF GRAM POSITIVE COCCI (GPC)
Staphylococcus
aureus
n =39
Isolate
Amikacin
Ciprofloxacin
Chloramphenicol
Cotrimoxazole
Cephalexin
Erythromycin
Penicillin
Rifampin
Vancomycin
25
10
25
23
21
25
20
39
38
%
64%
25.6%
64.1%
58.9%
53.8%
64.1%
51.2%
100%
97.4%
Staphylococcus
epidermidis
n =11
Isolate
8
3
6
3
3
2
5
11
11
%
72.7%
27.2%
54.5%
27.27%
27.27%
18.18%
45.4%
100%
100%
Staphylococcus Staphylococcus Staphylococcus Staphylococcus
schleiferilugdunensissaprophyticuswarneri
n =3n =2n =2n =2
Isolate
3
0
1
1
1
1
0
3
3
%`
100%
0
33.3%
33.3%
33.3%
33.3%
0
100%
100%
Isolate
1
1
2
1
1
1
1
2
2
%
50%
50%
100%
50%
50%
50%
50%
100%
100%
Isolate
1
1
1
0
0
0
0
2
2
%
50%
50%
50%
0
0
0
0
100%
100%
Isolate
1
1
1
1
0
0
0
2
2
%
50%
50%
50%
50%
0
0
0
100%
100%
Enterococcus
fecalis
n=1
Isolate
1
0
1
0
0
1
0
1
1
%
100%
0
100%
0
0
100%
0
100%
100%
Antibiotics
All GPC showed 100% sensitivity to Rifampin. All GPC except one strain of Staphylococcus aureus were sensitive to
Vancomycin.(97.4%) Staphylococcus schleiferi and Enterococcus fecalis were totally resistant to fluoroquinolones. Staphylococcus
saprophyticus , Staphylococcus warneri and Enterococcus fecalis exhibit multidrug resistance. They were all resistant to
cotrimoxazole,cephalexin and penicillin.When compared to coagulase negative Staphylococci,Staphylococcus aureus was more
sensitive to chloramphenicol,erythromycin,cephalexin,cotrimoxazole. But it showed less sensitivity than CONS to
fluoroquinolones and aminoglycosides.
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40
30
 20
 10
   0
SENSITIVITY PATTERN OF GPC
25
1
10
1
25
1
39
23
0
21
0
25
20
0
0
2
Staphylococcus aureus Staphylococcus saprophyticus
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TABLE-14:ANTIMICROBIAL SENSITIVITY PATTERNS OF GRAM NEGATIVE BACILLI (GNB)
Pseudomonas
aeruginosa
Antibiotics n =17
Klebsiella
pneumoniae
n=9
Proteus mirabilis
n=10
Escherichia coli
n=6
Acinetobacter
baumanii
n =4
Isolate Percentage Isolate Percentage Isolate Percentage Isolate Percentage Isolate Percentage
Amikacin
Gentamicin
Cefotaxime
Ceftazidime
Ciprofloxacin
Ofloxacin
Imipenem
Cefoperazone/
Sulbactum
9
3
6
6
3
5
17
13
52.9%
17.6%
35.2%
35.2%
17.6%
29.4%
100%
76.4%
8
5
2
2
1
5
9
8
88.8%
55.5%
22.2%
22.2%
11.1%
55.5%
100%
88.8%
6
2
4
4
1
2
10
9
60%
20%
40%
40%
10%
20%
100%
90%
4
1
2
2
1
1
6
4
66.6%
16.6%
33.3%
33.3%
16.6%
16.6%
100%
66.6%
2
2
1
1
1
4
4
4
50%
50%
25%
25%
25%
100%
100%
100%
Most of the gram negative bacilli showed high level resistance to third generation cephalosporins. All GNB showed 100%
sensitivity to imipenem. Except Pseudomonas aeruginosa and Escherichia coli all GNB showed good sensitivity to cefoperazone
sulbactum.
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ANTIMICROBIALSENSITIVITY PATTERNS OF GRAM NEGATIVE
BACILLI (GNB)
18
16
14
12
10
8
6
4
2
0
17
13
9
3
Ceftazidi
m e
Cefotaxi
m e
Gentam
icin
A m
ikacin
6 6
3
5
Ciproflox
acin
Ofloxacin
Pseudomonas aeruginosa
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Cefoperazo
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TABLE-15:DRUG RESISTANCE MECHANISM AMONG
THE PATHOGENS ISOLATED FROM CHRONIC
OSTEOMYELITIS
Number of
Multidrug
resistant isolate
n =43
Staphylococcus aureus
(n=39)
Methicillin resistant
S.aureus (MRSA)
Vancomycin intermediate
S.aureus(VISA)
Staphylococcus
epidermidis (n=11)
Methicillin resistant
Staphylococcus
epidermidis
Proteus mirabilis (n=10)
Extended spectrum β
lactamases
Escherichia coli (n =6)
Extended spectrum β
lactamases
Klebsiella pneumoniae
(n =9)
Extended spectrum β
lactamases
7 77.7% 43.79 96.09
4 66.6% 12.78 66.36
6 60% 26.24 87.8
6 54.5% 23.38 83.25
19
1
48.7%
2.5%
32.42 54.21
Total Pathogens (n=106) Percentage LCL UCL
Among the 106 aerobic bacteria isolated,43(40.5%) were multidrug
resistant. Coagulase negative Staphylococci (54.5%) exhibit more resistance
to Methicillin than S.aureus(48.7%). Among Enterobacteriaceae , Klebsiella
showed higher level of ESBL production(77.7%).
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TABLE-16:DETECTION OF ESBL PRODUCERS AMONG
THE GNB
No. of Positive Isolates
Pathogens
Screening Test
Proteus mirabilis( n=10)
Escherichia coli( n=6)
Klebsiella pneumoniae( n=9)
6
4
7
60%
66.6%
77.7%
6
4
7
DDST
60%
66.6%
77.7%
PCDDT
6
4
7
60%
66.6%
77.7%
PCDDT- phenotypic confirmatory disk diffusion test.
DDST- double disk diffusion synergy test.
77.7% of Klebsiella, 66.6% of E.coli, 60% of P.mirabilis, were ESBL
producers.
DETECTION OF ESBL PRODUCERS AMONG THE GNB
7
7
6
5
4
3
2
1
0
Screening Test
Proteus mirabilis( n=10)
DDST
Escherichia coli( n=6)
PCDDT
Klebsiella pneumoniae( n=9)
6
4
6
4 4
7
6
7
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TABLE-17:DRUG SUSCEPTIBILITY PATTERN OF
MYCOBACTERIUM TUBERCULOSIS
Drugs
Streptomycin
Isoniazid
Rifampicin
Ethambutol
Kanamycin
Ethionamide
Ofloxacin
S- SENSITIVE
Results
S
S
S
S
S
S
S
Drug susceptibility testing was done in National Institute for research
in Tuberculosis –Chetpet. The isolate was sensitive to all first line and second
line drugs.
TABLE-18: INTERPRETATION OF MIC OF VANCOMYCIN
FOR STAPHYLOCOCCUS AUREUS
Staphylococcus aureus
n=39
38
1
MIC value
<2g/l
8g/l
Interpretation
Sensitive
Intermediate
One strain of S.aureus showed intermediate sensitivity to vancomycin
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TABLE-19:MIC VALUES OF ANTIFUNGAL AGENTS FOR
CANDIDA TROPICALIS [ n=1]
Drug
Fluconazole
Amphotericin B
Itraconazole
Voriconazole
S- sensitive
The MIC value of all the four drugs were within their sensitive ranges.
MIC Value(µg/ml)
2
0.25
0.25
0.0625
S
S
S
S
Interpretation
70
DISCUSSION
This study was conducted in the Institute of Microbiology in
association with Institute of Orthopaedics, Rajiv Gandhi Government General
Hospital, Chennai- 600 003. 120 patients with chronic osteomyelitis were
included for the study.
The age group commonly affected was 31-40 (25%) followed by 21-30
(23.3%) and 12-20(19%)[Table-1].Muggeridge et al [73] (2002), Jayasimha et
al [74] (2003) also showed the similar age groups affected. In all the age
groups, males were commonly affected than females due to their occupation.
(outdoor work, construction work and high altitude work). In the present
study, 97 (80.83%) were males and 23 (19%) were females. Rao and sahu et
al [75] (1978) also showed nearer percentage of males (77% ) in their study. In
this study, male to female ratio was (4.2:1)[Table-1]. Samuel L.Turek et al [35]
also showed similar sex ratio distribution of male to female (4:1).
40% of the patients had duration of the illness from 7 months to 12
months.35.8% of patients had illness ranged from 13-24 months. About 55.8%
of patients presented within 1 year. [Table-2]. This was similar to the study
conducted by T.P. Srivastava P.C.Sen and V.K.Khanna et al, Varanasi, which
showed 55%.
Correlation of sex and duration of illness[Table-3] showed p
value=0.574. This is not statistically significant.Hence there is no relation
between sex and duration of illness.
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Correlationof age and duration of illness [Table-4] showed p
value=0.000.The mean age level in the duration of illness is statistically
significant.Group with largest duration of illness had age mean level as 52.3
which is an elevated age mean level.
In this study about 50.8% of patients had compound fracture due to
trauma being the commonest predisposing factor [Table-5]. This was slightly
higher than the study done by J.Dartnell et al [14] who showed 47% of cases
were posttraumatic. The next commonest predisposing factor was post
surgical (20%) followed by Diabetes mellitus with vascular insufficiency
(14.1%), followed by smoking/Alcohol(10.8%) as the commonest
predisposing factor. Gustilo et al [76] , showed infection rate in the setting of
open fracture was 50% which was similar to this study. Sudekamp.N et al [77]
in his retrospective study showed 56% of cases to be posttraumatic, which
was slightly higher than this study. Cherese Thomas et al [78] stated that
prevalence of Osteomyelitis in diabetic foot ranges from 10-20% .This study
showed 14% prevalence.
Tibia (45%) was the most common bone involved, followed by Femur
(29.1%) [Table-6].p=0.545.No statistical significance was found between the
male and female with respect to different bone sites.Holtom PD et al [79]
(1999), J.Dart nell et al [14] (2012), Muggeridge et al [73] (1999) from
Australia, V.L.Jayasimha et al [74] (2003) from Belgaum also showed similar
pattern of involvement.
Cross tabulation of site of bone and age group [Table-7] showed
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p=0.140.Thereis no statistical significance between different age groups and
site of bone infection.
Of the samples collected, 63(52.5%) were Sequestrum / Per operative
collections of pus and tissue fluids and 57%(47.5%) were swabs[Table-8 ].
Waldvogel et al (1970), Bhattacharya et al [80] (1974), Arora et al [81]
(1977) showed culture positivity of 95.3%, 95.2% and 95% respectively. In
this study culture positivity was 83.3%[Table-9]. This is in close correlation
with Dich et al [82] (1975) and Gulati et al [83] (2008) who showed 85% and
80% respectively. 16.6% yielded sterile cultures. Gulati et al (2008) showed
in his study that 20% of cultures were sterile. This was slightly higher than
this study.
Of the 63 per operative samples/ sequestrum, 59 (93.6%) was
monomicrobial and 1 was polymicrobial. In contrast, an increased number of
polymicrobial (12.2%) infections were noted in swabs, though monomicrobial
infection was the commonest type even in swabs (57.8%)[Table-
10].p=0.0000253,statistically significant. This strengthens the already
known fact that sequestrum and intra operative collections are better samples
than swabs, whenever possible.
Out of the total culture positives, 92(76.6%) showed growth in pure
form, 8 (6.6%) showed growth in mixed pattern. 6.6% of patients showed
mixed growth.[Table-10]. This was closely related to Ako-Nai A.K et al [28]
(2003) study which showed 5% of patients showing mixed infection.
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The common organism isolated was Staphylococcus aureus
(36.7%)[Table-11]. Andres F Zulauaga et al [84] 42%(2002), Arora et al
42%(1977), Henry et al [85] 42.2%(1990), Gulati et al [83] 43% (2008) also had
lower incidence of Staphylococcus aureus isolation. Pseudomonas aeruginosa
(16%) was the next common organism isolated. This percentage of isolation
coincided with Andres F Zuluaga et al (2002) who had the same 16% of
isolation. Bhattacharya et al (1974) and Henry et al (1990) had 15% and
17.25% of isolation respectively. The third common organism isolated was
Staphylococcus epidermidis (10.3%) .Andres F Zuluaga et al [84] (2002)
showed 10% isolation of coagulase negative staphylococci. Ako-Nai et al [28]
(2003) showed 12.8% isolation rate in his study. Other coagulase negative
staphylococci isolated were staphylococcus schleiferi (2.8%), Staphylococcus
saprophyticus, Staphylococcus lugdunensis and staphylococcus warneri (each
1.8%). Other organisms isolated were proteus mirabilis (9.4%) Klebsiella
pneumoniae (8.4%), Escherichia coli (5.6%) Acinetobacter baumanii (3.7%)
and Enterococcus fecalis (1%) Bhattacharya et al [81] and Perry et al [86]
showed 8.7% and 8.5% isolation of proteus which was slightly lower than this
study. The isolation rate of Klebsiella (8.4%) was slightly higher than Henry
et al who showed 6.9% of isolation. Gulati et al and Ako- Nai A.K et al
showed 5% and 5.1% of Escherichia coli in their studies. This isolation rate
coincided with this study. Andres F. Zuluga et al showed 10% isolation of
Acinetobacter. This was much higher than this study (3.7%). The isolation of
Enterococcus fecalis (1%) coincided with the study of Gulati et al who also
had similar isolation rate of 2%
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Outof 92 pure cultures yielded, one showed the growth of acid fast
bacilli Mycobacterium tuberculosis (0.8%)[Table-11]. H.L. Rieder et al [87] ,
has stated that only 1-2% of all tuberculosis cases affect the bone which
coincided with this study.
Candida tropicalis(0.8%) [Table-11] was the single fungal agent
isolated in this study. This patient had an ulcer in the mouth eroding into
maxillary bone. Maria N.Gamaletson et al [52] showed that Nonalbicans
Candida species caused 35% of Candida Osteomyelitis.
In mixed infections, Staphylococcus aureus and Pseudomonas
aeruginosa were commonly isolated in combinations. Escherichia coli and
Proteus mirabilis were also isolated in equal proportions [Table-12].
Staphylococcus aureus which was the commonest bacteria isolated in
this study showed 100% sensitivity to Rifampin, 97.4% sensitivity to
Vancomycin,64% sensitivity to Amikacin, Chloramphenicol and
Erythromycin, 51.2% to Penicillin,51.2% were sensitive to Cefoxitin[Table-
13]. Veena Ravi Prakash et al [88] (2004) showed 53.3% of MSSA which was
Mujumder et al [89]slightly higher than the present study (51.2%). (2001)
showed 47.10% of MSSA in his study. The second commonest isolate among
GPC, Staphylococcus epidermidis, showed 100% sensitivity to Vancomycin
and Rifampin, 72.7% to Amikacin 54.5% to Chloramphenicol, 45.4% to
Penicillin and 27.2% to Quinolones ,Cotrimoxazole.
48.7% of Staphylococcus aureus and 54.5% of Staphylococcus
epidermidis were found to be methicillin resistant[Table-15]. Veena Ravi
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Prakashet al showed 46.67% of MRSA. Among coagulase negative
Staphylococci, Staphylococcus schleiferi showed 100% resistance to
Ciprofloxacin and Penicillin. Similarly Staphylococcus saprophyticus and
Staphylococcus warneri were also totally resistant to Cephalexin,
Erythromycin and Penicillin. Other than Staphylococcus epidermidis, other
species of coagulase negative Staphylococci showed multi drug resistance
pattern. But all of them showed 100% sensitivity to Vancomycin. Sudha rani
J.N.etal [90] (2004) from tirupathi also showed 100% sensitivity of CONS to
Vancomycin.
The isolate of Enterococcus fecalis showed 100% sensitivity to
Rifampin and Vancomycin. It was totally resistant to Ciprofloxacin,
Cotrimoxazole, Cephalexin and Penicillin.
Vancomycin sensitivity was detected by Macrobroth dilution method.
38 out of 39 of S.aureus showed MIC within sensitive range (<2g/ml). One
isolate showed MIC range of 8 g/ml, and it was identified as Vancomycin
intermediate S.aureus (VISA).[Table-18]
Among gram negative isolates, Pseudomonas aeruginosa was the most
common isolate which showed 100% sensitivity to Imipenem, 76.4% to
cefoperazone sulbactum, 52.9% to Amikacin, 35.2% to Cefotaxime and
ceftazidime.[Table-14]. Gulati etal[83] from Amritsar,showed 89.5% sensitivity to
Cefoperazone sulbactum and Amikacin which were higher than this study.
Proteus mirabilis showed 100% sensitivity to Imipenem, 90% to
Cefoperazone/sulbactum, 60% to Amikacin, 30% to Cefotaxime and Ceftazidime.
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Gulatietal (2004) from Amritsar,showed 89.5% sensitivity to cefoperazone
sulbactum and 60.3% to amikacin which were closely similar to the present study.
Klebsiella pneumoniae showed 100% sensitivity to Imipenem, 90% to
cefoperazone/sulbactum and Amikacin[Table-14].Gulati etal (2004) showed
89.5% sensitivity to cefoperazone sulbactum which is coinciding with this study.
Among gram negative bacilli, production of extended spectrum 
lactamases was the mechanism of resistance in them. None of the isolates
were found to be MBL producers and AmpC producers. Strains of
Klebsiella,Proteus,E.coli were screened for ESBL production and confirmed
by PCDDT and DDST. [Table-16]
The acid fast bacilli Mycobacterium tuberculosis was sensitive to
Isoniazid, Rifampicin, Streptomycin, Ethambutol, Kanamycin, Ethionamide
and Ofloxacin. [Table-17]
MIC of Fluconazole, Amphotericin B, Itraconazole, Voriconazole for
Candida tropicalis was determined by Microbroth dilution method .MIC of
four drugs were within their sensitivity ranges for the isolate.[Table-19]
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SUMMARY
120 patients with chronic Osteomyelitis were taken up for the study.
The study showed
 The common age group affected was 20-40 years(48.3%) in both males
and females.
 40% of the patients had duration of illness between 7-12 months, followed
by 13-24 months(35.8%).
 The commonest predisposing factor leading to chronic Osteomyelitis was
trauma (50.8%) followed by Post surgical infection(20.1%).



100 samples showed culture positivit y(83.3%).
20 samples showed no growth(16.6%).
Monomicrobial growth occurred in 92 patients and Polymicrobial growth
occurred in 8 patients.
 Polymicrobial growth occurred more in swabs than in Sequestrum or intra
operative collections .
 Staphylococcus aureus was the most common organism isolated among
GPC(36.7%). Among GNB Pseudomonas aeruginosa (16%) was
commonly isolated.
 One acid fast bacilli and one fungal isolate were also isolated in this
study.
 Out of 39 isolates of Staphylococcus aureus, 19(48.7%) were MRSA. All
strains were sensitive to Rifampin (100%) and all except one(2.5%) were
sensitive to Vancomycin.
 Out of 11 isolates of Staphylococcus epidermidis, 6 were methicillin
resistant(54.5%). All strains were sensitive to Rifampin and Vancomycin
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 MIC of vancomycin for S.aureus was determined by macrobroth dilution
method.



Single strain identified as VISA had MIC value of 8 g/ml.
A single isolate of Enterococcus faecalis was sensitive to Vancomycin
Among 25 gram negative bacilli belonging to Enterobacteriaceae, 17(68%)
were found to produce Extended spectrum Beta lactamases(ESBL) by
screening method.
 All ESBLS were confirmed by Double disk synergy test (DDST),
phenotypic confirmatory disc diffusion test (PCDDT) and E-Strip method.



MIC of cefotaxime for E.Coli and Klebsiella were determined by E test.
All isolates had MIC within the sensitive range.
Mycobacterium tuberculosis was sensitive to all first line and second line
drugs.
 The fungal isolate,Candida tropicalis, was tested for antifungal
susceptibility by determining MIC by Microbroth dilution method.
 MIC of Fluconazole, Amphotericin B, Itraconazole and Voriconazole were
within their respective sensitive ranges.
79
CONCLUSION
This study on 120 patients admitted in orthopaedic wards and those
attending outpatient department, Rajiv Gandhi Government General Hospital,
Chennai with Chronic osteomyelitis was conducted to study the Predisposing
factors, Etiological agents, Antimicrobial Susceptibility Pattern and Drug
resistance pattern among the isolates.
Trauma especially road traffic accident with open fracture has been
found to be the major predisposing factor. Open fractures leading to
Osteomyelitis depends on the type of fracture, the level of contamination, the
degree of soft tissue injury and whether local and systemic antimicrobial
therapies have been administered. Additional predisposing factors include
Post surgical conditions, Diabetesmellitus, Smoking and Alcoholism. The
above predisposing factors leads to chronicity of infection, delayed healing
and exposure to prolonged antibiotic therapy, resulting in the overgrowth of
resistant strains.
56.6% were Aerobic gram positive cocci and 43.3% were Aerobic gram
negative bacilli. Among Gram positive cocci, Staphylococcus aureus (36.7%
)was the commonest pathogen isolated followed closely by Staphylococcus
epidermidis (10.5%).All gram positive cocci except one were sensitive to
Vancomycin and Rifampin. Among gram negative bacilli, all were sensitive to
Imipenem and 90% to Cefoperazone sulbactum. Pseudomonas had lower
sensitivity (76.4%) to Cefoperazone.
Multidrug resistance was seen in 40.5% of isolates from chronic
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Osteomyelitiscases. This factor stresses the need for culture and sensitivit y
and choosing appropriate narrow spectrum antibiotic for prolonged therapy (6
weeks). Also, the choice of empirical antibiotics, should be based both on
prevalence of local pathogen and antimicrobial susceptibility and on the
identification of patient with high risk of developing infections caused by
multidrug resistant organism.
As there are various factors in open fracture leading to chronic
Osteomyelitis ,each patient has to be routinely monitored after trauma and
treatment for developing Osteomyelitis. Treatment given in the early stage
will prevent dreadful complications and sequelae.
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APPENDIX
A. STAINS AND REAGENTS
I. Gram staining
Methyl violet (2%) l0g Methyl violet in l00ml
Absolute alcohol in 1litre of
distilled water (primary stain)
Grams Iodine l0g Iodine in 20g KI
(fixative)
Acetone
Carbolfuchsin
Decolourising agent
1% Secondary stain
II.Acid fast stain
Carbolfuchsin 3g basic fuchsin in 10 ml of 90-95%ethanol
with added 90 ml of 5% phenol
Acid-alcohol 3 ml conc HCL to 97 ml of 90-95%
ethanol.
Methylene blue counterstain 0.3g methylene blue in 100 ml of
dis.water
III. Lactophenol cotton blue stain
Lactic acid
Phenol
Cotton blue (dye)
Glycerol
Distilled water
20 ml
20ml
0.5g
40ml
20ml.
IV. 10% KOH
Potassium hydroxide
Glycerol
Distilled water
l0g
l0ml
80ml
B.MEDIA USED
1. Mac Conkey agar
Peptone
Sodium taurocholate
Distilled Water
Agar
2% neutral red in 50% ethanol
10% lactose solution
20g
5g
1 ltr
20g
3.5ml
l00ml
Dissolve peptone and taurocholate in water by heating. Add agar anddissolve it in
steamer. Adjust pH to 7.5. Add lactose and neutral red shake welland mix.Heat in free steam
(100°C) for 1 hour, then autoclave at 115°C for 15minutes.
2. Blood agar (5% sheep blood agar)
Peptone
NaCl
Distilled water
Agar
l0g
5g
1 Ltr
10g
Dissolve ingredients in distilled water by boiling, and add 5% sheepblood(sterile) at
55°C adjust pH to 7.4.
3. Chocolate agar
Sterile defibrinated blood
Nutrient Agar (melted)
10 ml
100 ml
When the temperature was about 75°C, sterile blood was added withconstant
agitation. After addition of blood, kept in water bath and heating wascontinued till the blood
changed to chocolate colour. Cooled to about 50° C and
poured about 15ml into petri dishes with sterile precaution.
4.Sabouraud’s dextrose agar
Dextrose
Peptone
Agar
Distilled water
pH
5. Mueller- Hinton Agar
Beef infusion
Caeseinhydrolysate
Starch
Agar
Distilled water
pH
Sterilise by autoclaving at 121ºC for 20 mins
6. Robertson’s Cooked Meat Broth
Fresh bullock heart
Water
Sodium hydroxide
Liquid filtered from
cooked meat
Peptone
NaCl
7.Chrome agar media
Glucose
Agar
Peptone
Chromogenic mix
Chloramphenicol
20gm
15gm
10gm
2 gm
0.5gm
500ml
2.5g
1.25g
500g
500ml
1mol/l 1.5ml
300ml
17.5g
1.5g
10g
1ltr
7.4
40g
l0g
20g
l000ml
5.5
Add to distilled water and mix water. Gently heat. Cool to 450-50 0c.Pour in sterile
petri dish
8.RPMI 1640
(Rose parker memorial institute) with glutamine, withoutbicarbonate, withphenolred
as pH indicator:
Dissolvepowdered media in 900 ml distilled water.Add MOPS buffer to a final
concentration of 0.165 mol/l and stir until dissolved.whilestirring,adjust the pH to 7.0 at 250c
using NAOH.Add additional water to bring media to a final volume of 1L.Filter sterilize and
store at 40c until use.
C. MEDIA REQUIRED FOR BIOCHEMICAL IDENTIFICATION
1.Oxidase Reagent
Tetra methyl p-phenylenediaminedihyrochloride- 1% aqueous solution.
2.Catalase
3% hydrogen peroxide
3.Indole test
Kovac’s reagent
Amyl or isoamyl alcohol 150ml
Para dimethyl amino benzaldehyde 10g
Concentrated hydrochloric acid 50ml
Dissolve the aldehyde in the alcohol and slowly add the acid. Prepare insmall
quantities and store in the refrigerator. Shake gently before use.
4.Christensen’s Urease test medium
Peptone
Sodium chloride
Dipotassium hydrogen phosphate
Phenol red
Agar
Distilled water
10% sterile solution of glucose
Sterile 20% urea solution
1g
5g
2g
6ml
20g
1 ltr
l0ml
l00ml
Sterilize the glucose and urea solutions by filtration. Prepare the basalmedium without
glucose and urea, adjust to pH 6.8-6.9 and sterilize byautoclaving in a flask at 121°C for
30min. Cool to about 50°C, add the glucose& urea, and tube the medium as slopes.
5.Simmon’s Citrate Medium
Koser’s medium
Agar
Bromothymol blue 0.2%
1 ltr
20g
40ml
Dispense, autoclave at 121°C for 15 min and allow to set as slopes
6.TripleSugar Iron medium
Beef extract
Yeast extract
Peptone
Glucose
Lactose
Sucrose
Ferric citrate
Sodium chloride
Sodumthiosulphate
Agar
Phenol red 0.2% solution
Distilled water
3g
3g
20g
1g
l0g
l0g
0.3g
5g
0.3g
12g
l2ml
1 ltr
Heat to dissolve the solids, add the indicator solution, mix and tube. Sterilize at121°C
for 15 min and cool to form slopes with deep butts.
7.Glucose phosphate broth
Peptone
Dipotassium hydrogen phosphate
Water
Glucose 10% solution
5g
5g
1 ltr
50ml
Dissolve the peptone and phosphate and adjust the pH to 7.6. Filterdispense in 5ml
amounts and sterilize at 121°C for 15min. Sterilize the glucosesolution by filtration and add
0.25ml to each tube.
Methyl Red Reagent
Methyl Red
Ethyl alcohol
Distilled water
VogesProskauer Reagent
Reagent A: Alpha naphthol
Ethyl alcohol
Reagent B: Potassium hydroxide
Distilled water
5g
100ml
40g
100ml
10mg
30ml
20ml
8.Peptonewater fermentation test medium.
To the basal medium of peptone water, add sterilised sugars of 1%indicator
bromothymol blue with Durham’s tube.
Basal medium peptone water
Sugar solutions:
Sugar
Dislilled water
pH
9.Mannitol motility medium
Agar
Peptone
Potassium nitrate
Mannitol
Phenol red indicator
Distilled water
pH
10. Phenolphthalein diphosphate agar
 Sterilize a 1% aqueous solution of sodium phenolphthalein diphosphateby
filtration and store at 4ºC
 Add 10ml of this solution to 1000ml melted nutrient agar cooled to 50ºCand pour
plates
 Grow the staphylococcus overnight at 37ºC on the medium
 Invert the plate and pour a few drops of ammonia solution SG 0.88 into
 the lid
 Read as positive a culture whose colonies turn bright pink within a few
 minutes. The colour soon fades.
l000ml
7.2
5g
1g
1g
2g
1ml
l00ml
7.6.
11. Potassium nitrate broth
Potassium nitrate (KN03)
Peptone
Distilled water
0.2gm
5.0gm
100ml
The above ingredients were mixed and transferred into tubes in 5 mlamount and
autoclaved.
12.Phenyl alanine deaminase test
Yeast Extract
Dl-Phenylalamine
Disodium hydrogen phosphate
Sodium Chloride
Agar
Distilled water
pH
3g
2g
lg
5g
12g
1 lr
7.4
Distributed in tubes and sterilized by autoclaving at 121° C for 1 5minutes, allowed to
solidify as long slopes.
13. Sugar fermentation medium
Peptone
Andrade’s indicator
Sugar to be tested
Water
15g
10 ml
20g
1litre
Andrade’s indicator is prepared from 0.5% aqueous acid fuchsin towhich sufficient
1M sodium hydroxide has been added to turn the colour of thesolution yellow.
Dissolve the peptone and Andrade’s indicator in 1litre of water and add20g of the
sugar; sugars to be tested generally include glucose, sucrose, lactoseand maltose. Distribute
3ml amounts in standard test tubes containing aninverted Durham tube. Sterilize by steaming
at 100 degree C for 30 min on 3consecutive days.
PROFORMA
 Name :




Age:
Sex:
Occupation:
Address:
IP no:
Ward:
Presenting complaints:
Duration of illness:
Site of bone:
Predisposing factors:
 Trauma
 Diabetes
 Peripheral vascular disease
 Chronic joint disease
 Alcoholism
 Intravenous drug abuse
 Chronic steroid use
 Immunosuppression
 Tuberculosis
 HIV and AIDS
Past history:






Prior surgery
Prior antibiotic therapy
Steroids
Immunosuppressive therapy
Smoking
Alcoholism
PHYSICALEXAMINATION:
Laboratory evaluation:
 Biochemical parameters :
Blood sugar
 Other investigations :
WBC count
ESR
CRP
Plain X-Ray
MRI in some cases
 Microbiological investigation:
Direct examination:
Gram’s stain:
AFB staining:
KOH mount:
Culture :
Aerobic bacterial:
Fungal:
Anaerobic culture:
Antimicrobial sensitivity pattern for bacterial and fungal isolates:
 
ABBREVIATIONS
ATCC
CLSI
CONS
American type culture collections
Clinical & Laboratory Standards Institute
Coagulase Negative Staphylocci
C.tropicalis
DDST
E.coli
ESBL
GNB
GPC
MBL
MIC
MRSA
MSSA
M.tuberculosis
PCDDT
RPMI 1640
S. aureus
S. epidermidis
S.lugdenensis
S.saprophyticus
S.schleiferi
S.warneri
Candida tropicalis
Double disk diffusion synergy test
Escherichia coli
Extended Spectrum Beta Lactamases
Gram-negative bacilli
Gram-positive cocci
Metallo Beta Lactamases
Minimum Inhibitory Concentration
Methicillin Resistant Staphylococcus aureus
Methicillin Sensitive Staphylococcus aureus
Mycobacterium tuberculosis
Phenotypic confirmatory disk diffusion test
Rose Parker Memorial Institute 1640
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus lugdunensis
Staphylococcus saprophyticus
Staphylococcus schleiferi
Staphylococcus warneri
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AGE SEX   group 1  gp‐2 gp‐3 gp‐4
 23MY
70MY
38MY
13FY
57MY
55
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36
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20
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22
17
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POST TRAUMATIC POST SURGICAL DIABETES
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SMOKING
   Y
Y
ALCOHOLIC HAEMATOGENOUS H/O PTB
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SITE OF BONE
   humerus
METATARSAL
SACRUM
FEMUR
FEMUR
TIBIA
TIBIA
TIBIA
METATARSAL
FEMUR
TIBIA
TIBIA
RIB
TIBIA
FEMUR
FEMUR
TIBIA
TIBIA
CALCANEUM
RIB
TIBIA
SKULL
RADIUS
FEMUR
SKULL
TIBIA
TIBIA
TIBIA
FEMUR
TIBIA
TIBIA
TIBIA
TIBIA
FIBULA
FEMUR
TIBIA
TIBIA
SPINE
HUMERUS
TIBIA
FEMUR
TIBIA
TIBIA
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TIBIA
DORSALSPINE
FEMUR
FEMUR
DORSALSPINE
TIBIA
TIBIA
FEMUR
TIBIA
TIBIA
TIBIA
TIBIA
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FEMUR
II PUS DISCHARGE SEQUESTRUM
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FEMUR
Y
Y
Y
Y
Y
Y
Y
Y
Y
INTRA OP COLLECTIONS
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              CULTURE
   PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUS AUREUS
E.COLI
STAPHYLOCOCCUSEPIDERMIDIS
PROTEUS MIRABILIS/
E.COLI
STAPHYLOCOCCUS AUREUS
PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUSEPIDERMIDIS
STAPHYLOCOCCUSEPIDERMIDIS
NG
STAPHYLOCOCCUS AUREUS
NG
PROTEUS MIRABILIS/
E.COLI
KLEBSIELLA PNEUMONIAE
ACINETOBACTER
PSEUDOMONAS AERUGINOSA/
STAPHYLOCOCCUS AUREUS
PROTEUS MIRABILIS
KLEBSIELLA PNEUMONIAE
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUSEPIDERMIDIS
KLEBSIELLA PNEUMONIAE
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS EPIDERMIDIS
KLEBSIELLA PNEUMONIAE/
STAPHYLOCOCCUS EPIDERMIDIS
STAPHYLOCOCCUSWARNERI
STAPHYLOCOCCUS AUREUS
KLEBSIELLA PNEUMONIAE
STAPHYLOCOCCUS AUREUS
ACINETOBACTER BAUMANII
PROTEUS MIRABILIS
PROTEUS MIRABILIS
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS LUGDUNENSIS
NG
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS/
PSEUDOMONASAERUGINOSA
STAPHYLOCOCCUS AUREUS
KLEBSIELLA PNEUMONIAE
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS WARNERI
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
E.COLI/
STAPHYLOCOCCUS AUREUS
ACINETOBACTERBAUMANII
STAPHYLOCOCCUS AUREUS
M.TB
NG
PROTEUS MIRABILIS
NG
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
STAPHLYOCOCCUS SAPROPHYTICUS
STAPHYLOCOCCUS AUREUS
PSEUDOMONAS AERUGINOSA
NG
PSEUDOMONAS AERUGINOSA
PSEUDOMONAS AERUGINOSA
STAPHLYOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
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AGE SEX   group 1  gp‐2 gp‐3 gp‐4
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 17MY
50MY
 67MY
41
25
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DIABETES SMOKING ALCOHOLIC HAEMATOGENOUS H/O PTB
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   FEMUR
TIBIA
FEMUR
TIBIA
FEMUR/TIBIA
TIBIA
FEMUR
FEMUR
FEMUR
CALCANEUM
TIBIA
CLAVICLE
FEMUR
TIBIA
TIBIA
FEMUR
CALCANEUM
FEMUR
FEMUR
STERNUM
FEMUR
TIBIA
TIBIA
TIBIA
FEMUR
STERNUM
TIBIA
METATARSAL
HUMERUS
TIBIA
METATARSAL
FRONTAL BONE
TIBIA
HUMERUS
TIBIA
METATARSAL
SACRUM
FEMUR
FEMUR
TIBIA
TIBIA
TIBIA
TIBIA
HUMERUS
TIBIA
FEMUR
CALCANEUM
FIBULA
TIBIA
FEMUR
TIBIA
METATARSAL
TIBIA
FEMUR
TIBIA
RADIUS
MAXILLA
TIBIA
TIBIA
FEMUR
TIBIA
II PUS DISCHARGE
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SEQUESTRUM
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              CULTURE
    STAPHYLOCOCCUS AUREUS
PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS SCHLEIFERI/
ENTEROCOCCI
ACINETOBACTER
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
NG
PSEUDOMONAS AERUGINOSA
NG
NG
PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUS SCHLEIFERI
NG
NG
NG
STAPHYLOCOCCUS EPIDERMIDIS
NG
STAPHYLOCOCCUS LUGDUNENSIS
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS/
PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUS EPIDERMIDIS
NG
NG
KLEBSIELLA pneumoniae
KLEBSIELLA PNEUMONIAE
STAPHYLOCOCCUS AUREUS
NG
NG
E.COLI
NG
PSEUDOMONAS AERUGINOSA
STAPHYLOCOCCUS AUREUS
STAPHYLOCOCCUS AUREUS
E.COLI
STAPHYLOCOCCUS EPIDERMIDIS
PROTEUS MIRABILIS
STAPHYLOCOCCUS AUREUS
S.EPIDERMIDIS
STAPHYLOCOCCUS AUREUS
NG
PSEUDOMONAS AERUGINOSA
PROTEUS MIRABILIS
STAPHYLOCOCCUS AUREUS
S.SAPROPHYTICUS
PSEUDOMONAS AERUGINOSA
PROTEUS MIRABILIS
STAPHYLOCOCCUS AUREUS
PSEUDOMONAS AERUGINOSA
S.SCHLEIFERI
STAPHYLOCOCCUS AUREUS
KLEBSIELLA PNEUMONIAE
PSEUDOMONAS AERUGINOSA
S.EPIDERMIDIS
CANDIDA TROPICALIS
STAPHYLOCOCCUS AUREUS
NG
PROTEUS MIRABILIS
PSEUDOMONAS AERUGINOSA
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SINUS WITH DISCHARGE
 
SEQUESTRUM
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X-RAY SHOWING CAVITY AND SEQUESTRUM
 
 
 
 
 
 
 
 
 
 
DIRECT GRAM STAIN SHOWING NEUTROPHILS
AND GRAM POSITIVE COCCI IN CLUSTERS
(STAPHYLOCOCCUS AUREUS)
Sequestrum 
Cavity 
119
  
DIRECT GRAM STAIN SHOWING PLENTY OF
NEUTROPHILS WITH GRAM NEGATIVE
BACILLI (PROTEUS MIRABILIS)
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STAPHYLOCOCCUS AUREUS IN NUTRIENT AGAR PLATE
WITH GOLDEN YELLOW PIGMENT
 
STAPHYLOCOCCUS AUREUS IN BLODO
AGAR PLATE WITH  β HEMOLYSIS
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TUBE COAGULASE-POSITIVE
 
TUBE COAGULASE-NEGATIVE
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PHOSPHATASE TEST-AFTER EXPOSURE TO
AMMONIA VAPOUR
 
NOVOBIOCIN SENSITIVE AND POLYMYXIN
RESISTANT S.EPIDERMIDIS
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BIOCHEMICAL REACTIONS OF
STAPHYLOCOCCUS EPIDERMIDIS
 
BIOCHEMICAL REACTIONS OF
STAPHYLOCOCCUS WARNERI
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BIOCHEMICAL REACTIONS OF
STAPHYLOCOCCUS SAPROPHYTICUS
 
BIOCHEMICAL REACTIONS OF
STAPHYLOCOCCUS SCHLEIFERI
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BIOCHEMICAL REACTIONS OF
STAPHYLOCOCCUS LUGDUNENSIS
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GROWTH OF KLEBSIELLA PNEUMONIAE ON
MAC CONKEY AGAR
 
BIOCHEMICAL REACTIONS OF KLEBSIELLA
PNEUMONIAE
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GROWTH OF PSEUDOMONAS AERUGINOSA ON
MACCONKEY AGAR
 
GROWTH OF PSEUDOMONAS AERUGINOSA ON
NUTRIENT AGAR
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BIOCHEMICAL REACTIONS OF PSEUDOMONAS
AERUGINOSA
 
BIOCHEMICAL REACTIONS OF ACINETOBACTER
BAUMANII
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METHICILLIN RESISTANT
STAPHYLOCOCCUS AUREUS
 
METHICILLIN SENSITIVE
STAPHYLOCOCCUS AUREUS
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GROWTH OF CANDIDA TROPICALIS ON SABOURAUD’S
DEXTROSE AGAR
 
GRAM STAIN OF CANDIDA TROPICALIS SHOWING
PSEUDOHYPHAE
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CANDIDA TROPICALIS ON
CHROMEAGAR PLATE
 
SUGAR FERMENTATION OF
CANDIDA TROPICALIS
 
132
ANTIMICROBIAL SENSITIVITY PATTERN OF
ESCHERICHIA COLI
 
133
ACINETOBACTER BAUMANII RESISTANT TO
PENICILLIN, AMPICILLIN ERYTHROMYCIN
 
DOUBLE DISK DIFFUSION
SYNERGY TEST
 
DDST 
134
PHENOTYPIC CONFIRMATORY
DISK DIFFUSION TEST
 
MIC OF CEFOTAXIME FOR KLEBSIELLA
HI-COMB METHOD
 
PCDDT 
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ESBL DETECTION BY E-STRIP METHOD
 
MINIMUM INHIBITORY CONCENTRATION OF
STAPHYLOCOCCUS AUREUS BY MACROBROTH
DILUTION METHOD.MIC-0.5µG/ML
 
136
MINIMUM INHIBITORY CONCENTRATION OF
VANCOMYCIN FORVANCOMYCIN INTERMEDIATE
STAPHYLOCOCCUS AUREUS (VISA) MIC-8µG/ML
 
MINIMUM INHIBITORY CONCENTRATION OF
ITRACONAZOLE FOR CANDIDA TROPICALIS
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MINIMUM INHIBITORY CONCENTRATION OF
AMPHOTERICIN-B FOR CANDIDA TROPICALIS
 
MINIMUM INHIBITORY CONCENTRATION OF
FLUCONAZOLE FOR CANDIDA TROPICALIS
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MINIMUM INHIBITORY CONCENTRATION OF
VORICONAZOLE FOR CANDIDA TROPICALIS
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